{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T16:18:01Z","timestamp":1788884281684,"version":"build-2803163510"},"reference-count":238,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T00:00:00Z","timestamp":1741132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T00:00:00Z","timestamp":1741132800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"crossref","award":["2020R1C1C1010613"],"award-info":[{"award-number":["2020R1C1C1010613"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"crossref","award":["2022R1A2C1006125"],"award-info":[{"award-number":["2022R1A2C1006125"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Chonnam National University Hwasun Hospital Institute for Biomedical Science","award":["HCRI24023"],"award-info":[{"award-number":["HCRI24023"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s12035-025-04797-6","type":"journal-article","created":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T09:30:49Z","timestamp":1741167049000},"page":"8824-8842","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Neuropsychiatric Abnormalities in Metabolic Disturbances: Interplay of Adipokines and Neurotransmission"],"prefix":"10.1007","volume":"62","author":[{"given":"So Yeong","family":"Cheon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juhyun","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,5]]},"reference":[{"issue":"9710","key":"4797_CR1","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0140-6736(09)61794-3","volume":"375","author":"RH Eckel","year":"2010","unstructured":"Eckel RH, Alberti KG, Grundy SM, Zimmet PZ (2010) The metabolic syndrome. Lancet 375(9710):181\u2013183. https:\/\/doi.org\/10.1016\/S0140-6736(09)61794-3","journal-title":"Lancet"},{"issue":"9468","key":"4797_CR2","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1016\/S0140-6736(05)66378-7","volume":"365","author":"RH Eckel","year":"2005","unstructured":"Eckel RH, Grundy SM, Zimmet PZ (2005) The metabolic syndrome. Lancet 365(9468):1415\u20131428. https:\/\/doi.org\/10.1016\/S0140-6736(05)66378-7","journal-title":"Lancet"},{"issue":"4","key":"4797_CR3","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1111\/j.1467-789X.2005.00221.x","volume":"6","author":"EN Liberopoulos","year":"2005","unstructured":"Liberopoulos EN, Mikhailidis DP, Elisaf MS (2005) Diagnosis and management of the metabolic syndrome in obesity. Obes Rev 6(4):283\u2013296. https:\/\/doi.org\/10.1111\/j.1467-789X.2005.00221.x","journal-title":"Obes Rev"},{"issue":"9","key":"4797_CR4","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1016\/j.metabol.2016.05.018","volume":"65","author":"C Procaccini","year":"2016","unstructured":"Procaccini C, Santopaolo M, Faicchia D, Colamatteo A, Formisano L, de Candia P, Galgani M, De Rosa V et al (2016) Role of metabolism in neurodegenerative disorders. Metabolism 65(9):1376\u20131390. https:\/\/doi.org\/10.1016\/j.metabol.2016.05.018","journal-title":"Metabolism"},{"issue":"1","key":"4797_CR5","doi-asserted-by":"publisher","first-page":"63","DOI":"10.31887\/DCNS.2018.20.1\/bpenninx","volume":"20","author":"B Penninx","year":"2018","unstructured":"Penninx B, Lange SMM (2018) Metabolic syndrome in psychiatric patients: overview, mechanisms, and implications. Dialogues Clin Neurosci 20(1):63\u201373. https:\/\/doi.org\/10.31887\/DCNS.2018.20.1\/bpenninx","journal-title":"Dialogues Clin Neurosci"},{"issue":"1","key":"4797_CR6","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/s41398-023-02447-w","volume":"13","author":"M Leutner","year":"2023","unstructured":"Leutner M, Dervic E, Bellach L, Klimek P, Thurner S, Kautzky A (2023) Obesity as pleiotropic risk state for metabolic and mental health throughout life. Transl Psychiatry 13(1):175. https:\/\/doi.org\/10.1038\/s41398-023-02447-w","journal-title":"Transl Psychiatry"},{"issue":"2","key":"4797_CR7","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.mce.2009.07.008","volume":"316","author":"JB Dixon","year":"2010","unstructured":"Dixon JB (2010) The effect of obesity on health outcomes. Mol Cell Endocrinol 316(2):104\u2013108. https:\/\/doi.org\/10.1016\/j.mce.2009.07.008","journal-title":"Mol Cell Endocrinol"},{"issue":"1","key":"4797_CR8","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1186\/s12872-023-03327-3","volume":"23","author":"D Fentie","year":"2023","unstructured":"Fentie D, Yibabie S (2023) Magnitude and associated factors of dyslipidemia among patients with severe mental illness in dire Dawa, Ethiopia: neglected public health concern. BMC Cardiovasc Disord 23(1):298. https:\/\/doi.org\/10.1186\/s12872-023-03327-3","journal-title":"BMC Cardiovasc Disord"},{"issue":"1","key":"4797_CR9","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1038\/s41467-023-37579-6","volume":"14","author":"HL Schaare","year":"2023","unstructured":"Schaare HL, Blochl M, Kumral D, Uhlig M, Lemcke L, Valk SL, Villringer A (2023) Associations between mental health, blood pressure and the development of hypertension. Nat Commun 14(1):1953. https:\/\/doi.org\/10.1038\/s41467-023-37579-6","journal-title":"Nat Commun"},{"issue":"2","key":"4797_CR10","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.genhosppsych.2013.11.002","volume":"36","author":"DJ Stein","year":"2014","unstructured":"Stein DJ, Aguilar-Gaxiola S, Alonso J, Bruffaerts R, de Jonge P, Liu Z, Miguel Caldas-de-Almeida J, O\u2019Neill S et al (2014) Associations between mental disorders and subsequent onset of hypertension. Gen Hosp Psychiatry 36(2):142\u2013149. https:\/\/doi.org\/10.1016\/j.genhosppsych.2013.11.002","journal-title":"Gen Hosp Psychiatry"},{"issue":"12","key":"4797_CR11","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1042\/CS20160136","volume":"130","author":"M Pigeyre","year":"2016","unstructured":"Pigeyre M, Yazdi FT, Kaur Y, Meyre D (2016) Recent progress in genetics, epigenetics and metagenomics unveils the pathophysiology of human obesity. Clin Sci (Lond) 130(12):943\u2013986. https:\/\/doi.org\/10.1042\/CS20160136","journal-title":"Clin Sci (Lond)"},{"key":"4797_CR12","doi-asserted-by":"publisher","first-page":"115012","DOI":"10.1016\/j.bcp.2022.115012","volume":"199","author":"RH Lustig","year":"2022","unstructured":"Lustig RH, Collier D, Kassotis C, Roepke TA, Kim MJ, Blanc E, Barouki R, Bansal A et al (2022) Obesity I: Overview and molecular and biochemical mechanisms. Biochem Pharmacol 199:115012. https:\/\/doi.org\/10.1016\/j.bcp.2022.115012","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"4797_CR13","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1002\/hbm.20870","volume":"31","author":"CA Raji","year":"2010","unstructured":"Raji CA, Ho AJ, Parikshak NN, Becker JT, Lopez OL, Kuller LH, Hua X, Leow AD et al (2010) Brain structure and obesity. Hum Brain Mapp 31(3):353\u2013364. https:\/\/doi.org\/10.1002\/hbm.20870","journal-title":"Hum Brain Mapp"},{"issue":"12","key":"4797_CR14","doi-asserted-by":"publisher","first-page":"e4872","DOI":"10.1210\/clinem\/dgab421","volume":"106","author":"A Caron","year":"2021","unstructured":"Caron A, Jane Michael N (2021) New Horizons: Is Obesity a Disorder of Neurotransmission? J Clin Endocrinol Metab 106(12):e4872\u2013e4886. https:\/\/doi.org\/10.1210\/clinem\/dgab421","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"4797_CR15","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1515\/tnsci-2020-0099","volume":"11","author":"RSM Labban","year":"2020","unstructured":"Labban RSM, Alfawaz H, Almnaizel AT, Hassan WM, Bhat RS, Moubayed NM, Bjorklund G, El-Ansary A (2020) High-fat diet-induced obesity and impairment of brain neurotransmitter pool. Transl Neurosci 11(1):147\u2013160. https:\/\/doi.org\/10.1515\/tnsci-2020-0099","journal-title":"Transl Neurosci"},{"issue":"2","key":"4797_CR16","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1017\/S0954422421000196","volume":"35","author":"CW Wallace","year":"2022","unstructured":"Wallace CW, Fordahl SC (2022) Obesity and dietary fat influence dopamine neurotransmission: exploring the convergence of metabolic state, physiological stress, and inflammation on dopaminergic control of food intake. Nutr Res Rev 35(2):236\u2013251. https:\/\/doi.org\/10.1017\/S0954422421000196","journal-title":"Nutr Res Rev"},{"key":"4797_CR17","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/1746-6148-10-113","volume":"10","author":"HJ Park","year":"2014","unstructured":"Park HJ, Lee SE, Oh JH, Seo KW, Song KH (2014) Leptin, adiponectin and serotonin levels in lean and obese dogs. BMC Vet Res 10:113. https:\/\/doi.org\/10.1186\/1746-6148-10-113","journal-title":"BMC Vet Res"},{"key":"4797_CR18","doi-asserted-by":"publisher","first-page":"114847","DOI":"10.1016\/j.biopha.2023.114847","volume":"163","author":"A Arjunan","year":"2023","unstructured":"Arjunan A, Song J (2023) Pharmacological and physiological roles of adipokines and myokines in metabolic-related dementia. Biomed Pharmacother 163:114847. https:\/\/doi.org\/10.1016\/j.biopha.2023.114847","journal-title":"Biomed Pharmacother"},{"issue":"9","key":"4797_CR19","doi-asserted-by":"publisher","first-page":"e12997","DOI":"10.1111\/eci.12997","volume":"48","author":"X Unamuno","year":"2018","unstructured":"Unamuno X, Gomez-Ambrosi J, Rodriguez A, Becerril S, Fruhbeck G, Catalan V (2018) Adipokine dysregulation and adipose tissue inflammation in human obesity. Eur J Clin Invest 48(9):e12997. https:\/\/doi.org\/10.1111\/eci.12997","journal-title":"Eur J Clin Invest"},{"issue":"1","key":"4797_CR20","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s12974-016-0530-x","volume":"13","author":"A Parimisetty","year":"2016","unstructured":"Parimisetty A, Dorsemans AC, Awada R, Ravanan P, Diotel N, Lefebvre d\u2019Hellencourt C (2016) Secret talk between adipose tissue and central nervous system via secreted factors-an emerging frontier in the neurodegenerative research. J Neuroinflammation 13(1):67. https:\/\/doi.org\/10.1186\/s12974-016-0530-x","journal-title":"J Neuroinflammation"},{"issue":"1\u20133","key":"4797_CR21","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.ejphar.2004.04.020","volume":"493","author":"L Brunetti","year":"2004","unstructured":"Brunetti L, Orlando G, Recinella L, Michelotto B, Ferrante C, Vacca M (2004) Resistin, but not adiponectin, inhibits dopamine and norepinephrine release in the hypothalamus. Eur J Pharmacol 493(1\u20133):41\u201344. https:\/\/doi.org\/10.1016\/j.ejphar.2004.04.020","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"4797_CR22","doi-asserted-by":"publisher","first-page":"174","DOI":"10.7570\/jomes20021","volume":"29","author":"P Kordestani-Moghadam","year":"2020","unstructured":"Kordestani-Moghadam P, Assari S, Nouriyengejeh S, Mohammadipour F, Pourabbasi A (2020) Cognitive impairments and associated structural brain changes in metabolic syndrome and implications of neurocognitive intervention. J Obes Metab Syndr 29(3):174\u2013179. https:\/\/doi.org\/10.7570\/jomes20021","journal-title":"J Obes Metab Syndr"},{"key":"4797_CR23","doi-asserted-by":"publisher","first-page":"6613385","DOI":"10.1155\/2021\/6613385","volume":"2021","author":"E Gomez-Apo","year":"2021","unstructured":"Gomez-Apo E, Mondragon-Maya A, Ferrari-Diaz M, Silva-Pereyra J (2021) Structural brain changes associated with overweight and obesity. J Obes 2021:6613385. https:\/\/doi.org\/10.1155\/2021\/6613385","journal-title":"J Obes"},{"key":"4797_CR24","doi-asserted-by":"publisher","first-page":"103179","DOI":"10.1016\/j.nicl.2022.103179","volume":"36","author":"L Zapparoli","year":"2022","unstructured":"Zapparoli L, Devoto F, Giannini G, Zonca S, Gallo F, Paulesu E (2022) Neural structural abnormalities behind altered brain activation in obesity: Evidence from meta-analyses of brain activation and morphometric data. Neuroimage Clin 36:103179. https:\/\/doi.org\/10.1016\/j.nicl.2022.103179","journal-title":"Neuroimage Clin"},{"issue":"7","key":"4797_CR25","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1002\/hbm.22021","volume":"34","author":"F Kurth","year":"2013","unstructured":"Kurth F, Levitt JG, Phillips OR, Luders E, Woods RP, Mazziotta JC, Toga AW, Narr KL (2013) Relationships between gray matter, body mass index, and waist circumference in healthy adults. Hum Brain Mapp 34(7):1737\u20131746. https:\/\/doi.org\/10.1002\/hbm.22021","journal-title":"Hum Brain Mapp"},{"issue":"10","key":"4797_CR26","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1212\/01.wnl.0000141850.47773.5f","volume":"63","author":"D Gustafson","year":"2004","unstructured":"Gustafson D, Lissner L, Bengtsson C, Bjorkelund C, Skoog I (2004) A 24-year follow-up of body mass index and cerebral atrophy. Neurology 63(10):1876\u20131881. https:\/\/doi.org\/10.1212\/01.wnl.0000141850.47773.5f","journal-title":"Neurology"},{"issue":"4","key":"4797_CR27","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1007\/s13679-020-00412-y","volume":"9","author":"H Tanaka","year":"2020","unstructured":"Tanaka H, Gourley DD, Dekhtyar M, Haley AP (2020) Cognition, Brain Structure, and Brain Function in Individuals with Obesity and Related Disorders. Curr Obes Rep 9(4):544\u2013549. https:\/\/doi.org\/10.1007\/s13679-020-00412-y","journal-title":"Curr Obes Rep"},{"issue":"Suppl 1","key":"4797_CR28","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.neurobiolaging.2005.08.019","volume":"26","author":"MF Elias","year":"2005","unstructured":"Elias MF, Elias PK, Sullivan LM, Wolf PA, D\u2019Agostino RB (2005) Obesity, diabetes and cognitive deficit: The Framingham Heart Study. Neurobiol Aging 26(Suppl 1):11\u201316. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2005.08.019","journal-title":"Neurobiol Aging"},{"issue":"7504","key":"4797_CR29","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1136\/bmj.38446.466238.E0","volume":"330","author":"RA Whitmer","year":"2005","unstructured":"Whitmer RA, Gunderson EP, Barrett-Connor E, Quesenberry CP Jr, Yaffe K (2005) Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study. BMJ 330(7504):1360. https:\/\/doi.org\/10.1136\/bmj.38446.466238.E0","journal-title":"BMJ"},{"key":"4797_CR30","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.neubiorev.2017.11.020","volume":"84","author":"Y Yang","year":"2018","unstructured":"Yang Y, Shields GS, Guo C, Liu Y (2018) Executive function performance in obesity and overweight individuals: A meta-analysis and review. Neurosci Biobehav Rev 84:225\u2013244. https:\/\/doi.org\/10.1016\/j.neubiorev.2017.11.020","journal-title":"Neurosci Biobehav Rev"},{"issue":"2","key":"4797_CR31","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/s41419-018-1199-0","volume":"10","author":"XK Tong","year":"2019","unstructured":"Tong XK, Trigiani LJ, Hamel E (2019) High cholesterol triggers white matter alterations and cognitive deficits in a mouse model of cerebrovascular disease: benefits of simvastatin. Cell Death Dis 10(2):89. https:\/\/doi.org\/10.1038\/s41419-018-1199-0","journal-title":"Cell Death Dis"},{"issue":"1","key":"4797_CR32","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12944-016-0401-6","volume":"16","author":"W Yang","year":"2017","unstructured":"Yang W, Shi H, Zhang J, Shen Z, Zhou G, Hu M (2017) Effects of the duration of hyperlipidemia on cerebral lipids, vessels and neurons in rats. Lipids Health Dis 16(1):26. https:\/\/doi.org\/10.1186\/s12944-016-0401-6","journal-title":"Lipids Health Dis"},{"issue":"1","key":"4797_CR33","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13024-017-0167-y","volume":"12","author":"C Ma","year":"2017","unstructured":"Ma C, Yin Z, Zhu P, Luo J, Shi X, Gao X (2017) Blood cholesterol in late-life and cognitive decline: a longitudinal study of the Chinese elderly. Mol Neurodegener 12(1):24. https:\/\/doi.org\/10.1186\/s13024-017-0167-y","journal-title":"Mol Neurodegener"},{"issue":"1","key":"4797_CR34","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s12944-016-0320-6","volume":"15","author":"Q He","year":"2016","unstructured":"He Q, Li Q, Zhao J, Wu T, Ji L, Huang G, Ma F (2016) Relationship between plasma lipids and mild cognitive impairment in the elderly Chinese: a case-control study. Lipids Health Dis 15(1):146. https:\/\/doi.org\/10.1186\/s12944-016-0320-6","journal-title":"Lipids Health Dis"},{"issue":"6","key":"4797_CR35","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1037\/neu0000335","volume":"31","author":"V Parthasarathy","year":"2017","unstructured":"Parthasarathy V, Frazier DT, Bettcher BM, Jastrzab L, Chao L, Reed B, Mungas D, Weiner M et al (2017) Triglycerides are negatively correlated with cognitive function in nondemented aging adults. Neuropsychology 31(6):682\u2013688. https:\/\/doi.org\/10.1037\/neu0000335","journal-title":"Neuropsychology"},{"issue":"8","key":"4797_CR36","doi-asserted-by":"publisher","first-page":"e498","DOI":"10.1016\/S2666-7568(21)00150-1","volume":"2","author":"M Iwagami","year":"2021","unstructured":"Iwagami M, Qizilbash N, Gregson J, Douglas I, Johnson M, Pearce N, Evans S, Pocock S (2021) Blood cholesterol and risk of dementia in more than 1.8 million people over two decades: a retrospective cohort study. Lancet Healthy Longev 2(8):e498\u2013e506. https:\/\/doi.org\/10.1016\/S2666-7568(21)00150-1","journal-title":"Lancet Healthy Longev"},{"issue":"3","key":"4797_CR37","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1093\/cvr\/cvu148","volume":"103","author":"C Vitali","year":"2014","unstructured":"Vitali C, Wellington CL, Calabresi L (2014) HDL and cholesterol handling in the brain. Cardiovasc Res 103(3):405\u2013413. https:\/\/doi.org\/10.1093\/cvr\/cvu148","journal-title":"Cardiovasc Res"},{"issue":"3","key":"4797_CR38","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.amjmed.2009.08.015","volume":"123","author":"D Zambon","year":"2010","unstructured":"Zambon D, Quintana M, Mata P, Alonso R, Benavent J, Cruz-Sanchez F, Gich J, Pocovi M et al (2010) Higher incidence of mild cognitive impairment in familial hypercholesterolemia. Am J Med 123(3):267\u2013274. https:\/\/doi.org\/10.1016\/j.amjmed.2009.08.015","journal-title":"Am J Med"},{"issue":"23","key":"4797_CR39","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1212\/WNL.0000000000001655","volume":"84","author":"G Weinstein","year":"2015","unstructured":"Weinstein G, Maillard P, Himali JJ, Beiser AS, Au R, Wolf PA, Seshadri S, DeCarli C (2015) Glucose indices are associated with cognitive and structural brain measures in young adults. Neurology 84(23):2329\u20132337. https:\/\/doi.org\/10.1212\/WNL.0000000000001655","journal-title":"Neurology"},{"issue":"9","key":"4797_CR40","doi-asserted-by":"publisher","first-page":"e73697","DOI":"10.1371\/journal.pone.0073697","volume":"8","author":"ME Mortby","year":"2013","unstructured":"Mortby ME, Janke AL, Anstey KJ, Sachdev PS, Cherbuin N (2013) High \u201cnormal\u201d blood glucose is associated with decreased brain volume and cognitive performance in the 60s: the PATH through life study. PLoS ONE 8(9):e73697. https:\/\/doi.org\/10.1371\/journal.pone.0073697","journal-title":"PLoS ONE"},{"key":"4797_CR41","doi-asserted-by":"publisher","first-page":"644159","DOI":"10.3389\/fendo.2021.644159","volume":"12","author":"R Liu","year":"2021","unstructured":"Liu R, Guan S, Gao Z, Wang J, Xu J, Hao Z, Zhang Y, Yang S et al (2021) Pathological hyperinsulinemia and hyperglycemia in the impaired glucose tolerance stage mediate endothelial dysfunction through miR-21, PTEN\/AKT\/eNOS, and MARK\/ET-1 pathways. Front Endocrinol (Lausanne) 12:644159. https:\/\/doi.org\/10.3389\/fendo.2021.644159","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"8","key":"4797_CR42","doi-asserted-by":"publisher","first-page":"2434","DOI":"10.1002\/hbm.25377","volume":"42","author":"R Lu","year":"2021","unstructured":"Lu R, Aziz NA, Diers K, Stocker T, Reuter M, Breteler MMB (2021) Insulin resistance accounts for metabolic syndrome-related alterations in brain structure. Hum Brain Mapp 42(8):2434\u20132444. https:\/\/doi.org\/10.1002\/hbm.25377","journal-title":"Hum Brain Mapp"},{"issue":"2","key":"4797_CR43","doi-asserted-by":"publisher","first-page":"443","DOI":"10.2337\/dc12-0922","volume":"36","author":"AA Willette","year":"2013","unstructured":"Willette AA, Xu G, Johnson SC, Birdsill AC, Jonaitis EM, Sager MA, Hermann BP, La Rue A et al (2013) Insulin resistance, brain atrophy, and cognitive performance in late middle-aged adults. Diabetes Care 36(2):443\u2013449. https:\/\/doi.org\/10.2337\/dc12-0922","journal-title":"Diabetes Care"},{"issue":"3","key":"4797_CR44","doi-asserted-by":"publisher","first-page":"e149","DOI":"10.1038\/emm.2015.3","volume":"47","author":"B Kim","year":"2015","unstructured":"Kim B, Feldman EL (2015) Insulin resistance as a key link for the increased risk of cognitive impairment in the metabolic syndrome. Exp Mol Med 47(3):e149. https:\/\/doi.org\/10.1038\/emm.2015.3","journal-title":"Exp Mol Med"},{"issue":"4","key":"4797_CR45","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1192\/bjp.bp.114.153536","volume":"206","author":"CL Allan","year":"2015","unstructured":"Allan CL, Zsoldos E, Filippini N, Sexton CE, Topiwala A, Valkanova V, Singh-Manoux A, Tabak AG et al (2015) Lifetime hypertension as a predictor of brain structure in older adults: cohort study with a 28-year follow-up. Br J Psychiatry 206(4):308\u2013315. https:\/\/doi.org\/10.1192\/bjp.bp.114.153536","journal-title":"Br J Psychiatry"},{"issue":"8","key":"4797_CR46","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1161\/CIRCULATIONAHA.110.978114","volume":"123","author":"I Hajjar","year":"2011","unstructured":"Hajjar I, Quach L, Yang F, Chaves PH, Newman AB, Mukamal K, Longstreth W Jr, Inzitari M et al (2011) Hypertension, white matter hyperintensities, and concurrent impairments in mobility, cognition, and mood: the cardiovascular health study. Circulation 123(8):858\u2013865. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.110.978114","journal-title":"Circulation"},{"issue":"9","key":"4797_CR47","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1093\/gerona\/glp075","volume":"64","author":"I Hajjar","year":"2009","unstructured":"Hajjar I, Yang F, Sorond F, Jones RN, Milberg W, Cupples LA, Lipsitz LA (2009) A novel aging phenotype of slow gait, impaired executive function, and depressive symptoms: relationship to blood pressure and other cardiovascular risks. J Gerontol A Biol Sci Med Sci 64(9):994\u20131001. https:\/\/doi.org\/10.1093\/gerona\/glp075","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"10","key":"4797_CR48","doi-asserted-by":"publisher","first-page":"2376","DOI":"10.2337\/db09-0047","volume":"58","author":"AM Vincent","year":"2009","unstructured":"Vincent AM, Hayes JM, McLean LL, Vivekanandan-Giri A, Pennathur S, Feldman EL (2009) Dyslipidemia-induced neuropathy in mice: the role of oxLDL\/LOX-1. Diabetes 58(10):2376\u20132385. https:\/\/doi.org\/10.2337\/db09-0047","journal-title":"Diabetes"},{"issue":"2","key":"4797_CR49","doi-asserted-by":"publisher","first-page":"fcad059","DOI":"10.1093\/braincomms\/fcad059","volume":"5","author":"MM Andrade","year":"2023","unstructured":"Andrade MM, Fernandes C, Forny-Germano L, Goncalves RA, Gomes M, Castro-Fonseca E, Ramos-Lobo AM, Tovar-Moll F et al (2023) Alteration in the number of neuronal and non-neuronal cells in mouse models of obesity. Brain Commun 5(2):fcad059. https:\/\/doi.org\/10.1093\/braincomms\/fcad059","journal-title":"Brain Commun"},{"issue":"5667","key":"4797_CR50","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1126\/science.1089459","volume":"304","author":"S Pinto","year":"2004","unstructured":"Pinto S, Roseberry AG, Liu H, Diano S, Shanabrough M, Cai X, Friedman JM, Horvath TL (2004) Rapid rewiring of arcuate nucleus feeding circuits by leptin. Science 304(5667):110\u2013115. https:\/\/doi.org\/10.1126\/science.1089459","journal-title":"Science"},{"issue":"33","key":"4797_CR51","doi-asserted-by":"publisher","first-page":"14875","DOI":"10.1073\/pnas.1004282107","volume":"107","author":"TL Horvath","year":"2010","unstructured":"Horvath TL, Sarman B, Garcia-Caceres C, Enriori PJ, Sotonyi P, Shanabrough M, Borok E, Argente J et al (2010) Synaptic input organization of the melanocortin system predicts diet-induced hypothalamic reactive gliosis and obesity. Proc Natl Acad Sci U S A 107(33):14875\u201314880. https:\/\/doi.org\/10.1073\/pnas.1004282107","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"44","key":"4797_CR52","doi-asserted-by":"publisher","first-page":"eadh2884","DOI":"10.1126\/sciadv.adh2884","volume":"9","author":"X Wang","year":"2023","unstructured":"Wang X, Wu X, Wu H, Xiao H, Hao S, Wang B, Li C, Bleymehl K et al (2023) Neural adaption in midbrain GABAergic cells contributes to high-fat diet-induced obesity. Sci Adv 9(44):eadh2884. https:\/\/doi.org\/10.1126\/sciadv.adh2884","journal-title":"Sci Adv"},{"issue":"3","key":"4797_CR53","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1111\/obr.12243","volume":"16","author":"KC de Git","year":"2015","unstructured":"de Git KC, Adan RA (2015) Leptin resistance in diet-induced obesity: the role of hypothalamic inflammation. Obes Rev 16(3):207\u2013224. https:\/\/doi.org\/10.1111\/obr.12243","journal-title":"Obes Rev"},{"issue":"4","key":"4797_CR54","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/s12276-022-00759-3","volume":"54","author":"MS Kim","year":"2022","unstructured":"Kim MS (2022) The neural basis of weight control and obesity. Exp Mol Med 54(4):347\u2013348. https:\/\/doi.org\/10.1038\/s12276-022-00759-3","journal-title":"Exp Mol Med"},{"issue":"6447","key":"4797_CR55","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1126\/science.aax1184","volume":"364","author":"MA Rossi","year":"2019","unstructured":"Rossi MA, Basiri ML, McHenry JA, Kosyk O, Otis JM, van den Munkhof HE, Bryois J, Hubel C et al (2019) Obesity remodels activity and transcriptional state of a lateral hypothalamic brake on feeding. Science 364(6447):1271\u20131274. https:\/\/doi.org\/10.1126\/science.aax1184","journal-title":"Science"},{"issue":"7","key":"4797_CR56","doi-asserted-by":"publisher","first-page":"e49210","DOI":"10.15252\/embr.201949210","volume":"21","author":"C Zhu","year":"2020","unstructured":"Zhu C, Xu Y, Jiang Z, Tian JB, Cassidy RM, Cai ZL, Shu G, Xu Y et al (2020) Disrupted hypothalamic CRH neuron responsiveness contributes to diet-induced obesity. EMBO Rep 21(7):e49210. https:\/\/doi.org\/10.15252\/embr.201949210","journal-title":"EMBO Rep"},{"issue":"5","key":"4797_CR57","doi-asserted-by":"publisher","first-page":"205","DOI":"10.3892\/etm.2023.11904","volume":"25","author":"Q Zheng","year":"2023","unstructured":"Zheng Q, Han Y, Fan M, Gao X, Ma M, Xu J, Liu S, Ge J (2023) Potential role of TREM2 in high cholesterol-induced cell injury and metabolic dysfunction in SH-SY5Y cells. Exp Ther Med 25(5):205. https:\/\/doi.org\/10.3892\/etm.2023.11904","journal-title":"Exp Ther Med"},{"issue":"1","key":"4797_CR58","doi-asserted-by":"publisher","first-page":"12651","DOI":"10.1038\/s41598-020-69454-5","volume":"10","author":"M Korinek","year":"2020","unstructured":"Korinek M, Gonzalez-Gonzalez IM, Smejkalova T, Hajdukovic D, Skrenkova K, Krusek J, Horak M, Vyklicky L (2020) Cholesterol modulates presynaptic and postsynaptic properties of excitatory synaptic transmission. Sci Rep 10(1):12651. https:\/\/doi.org\/10.1038\/s41598-020-69454-5","journal-title":"Sci Rep"},{"issue":"4","key":"4797_CR59","doi-asserted-by":"publisher","first-page":"109889","DOI":"10.1016\/j.celrep.2021.109889","volume":"37","author":"SA Berghoff","year":"2021","unstructured":"Berghoff SA, Spieth L, Sun T, Hosang L, Depp C, Sasmita AO, Vasileva MH, Scholz P et al (2021) Neuronal cholesterol synthesis is essential for repair of chronically demyelinated lesions in mice. Cell Rep 37(4):109889. https:\/\/doi.org\/10.1016\/j.celrep.2021.109889","journal-title":"Cell Rep"},{"issue":"4","key":"4797_CR60","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1007\/s13238-014-0131-3","volume":"6","author":"J Zhang","year":"2015","unstructured":"Zhang J, Liu Q (2015) Cholesterol metabolism and homeostasis in the brain. Protein Cell 6(4):254\u2013264. https:\/\/doi.org\/10.1007\/s13238-014-0131-3","journal-title":"Protein Cell"},{"issue":"7","key":"4797_CR61","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1073\/pnas.0305799101","volume":"101","author":"RG Cutler","year":"2004","unstructured":"Cutler RG, Kelly J, Storie K, Pedersen WA, Tammara A, Hatanpaa K, Troncoso JC, Mattson MP (2004) Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer\u2019s disease. Proc Natl Acad Sci U S A 101(7):2070\u20132075. https:\/\/doi.org\/10.1073\/pnas.0305799101","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4797_CR62","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/1750-1326-9-60","volume":"9","author":"C Marquer","year":"2014","unstructured":"Marquer C, Laine J, Dauphinot L, Hanbouch L, Lemercier-Neuillet C, Pierrot N, Bossers K, Le M et al (2014) Increasing membrane cholesterol of neurons in culture recapitulates Alzheimer\u2019s disease early phenotypes. Mol Neurodegener 9:60. https:\/\/doi.org\/10.1186\/1750-1326-9-60","journal-title":"Mol Neurodegener"},{"issue":"3","key":"4797_CR63","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1080\/09687680701805541","volume":"25","author":"J Guo","year":"2008","unstructured":"Guo J, Chi S, Xu H, Jin G, Qi Z (2008) Effects of cholesterol levels on the excitability of rat hippocampal neurons. Mol Membr Biol 25(3):216\u2013223. https:\/\/doi.org\/10.1080\/09687680701805541","journal-title":"Mol Membr Biol"},{"issue":"1","key":"4797_CR64","doi-asserted-by":"publisher","first-page":"6013","DOI":"10.1038\/s41598-021-85502-0","volume":"11","author":"YS Lin","year":"2021","unstructured":"Lin YS, Liu CK, Lee HC, Chou MC, Ke LY, Chen CH, Chen SL (2021) Electronegative very-low-density lipoprotein induces brain inflammation and cognitive dysfunction in mice. Sci Rep 11(1):6013. https:\/\/doi.org\/10.1038\/s41598-021-85502-0","journal-title":"Sci Rep"},{"issue":"1","key":"4797_CR65","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1186\/s12967-022-03786-w","volume":"20","author":"Q Wang","year":"2022","unstructured":"Wang Q, Zang F, He C, Zhang Z, Xie C, Alzheimer\u2019s Disease Neuroimaging I (2022) Dyslipidemia induced large-scale network connectivity abnormality facilitates cognitive decline in the Alzheimer\u2019s disease. J Transl Med 20(1):567. https:\/\/doi.org\/10.1186\/s12967-022-03786-w","journal-title":"J Transl Med"},{"issue":"4","key":"4797_CR66","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1001\/archneur.1987.00520160052014","volume":"44","author":"JS Meyer","year":"1987","unstructured":"Meyer JS, Rogers RL, Mortel KF, Judd BW (1987) Hyperlipidemia is a risk factor for decreased cerebral perfusion and stroke. Arch Neurol 44(4):418\u2013422. https:\/\/doi.org\/10.1001\/archneur.1987.00520160052014","journal-title":"Arch Neurol"},{"issue":"6","key":"4797_CR67","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1038\/jcbfm.2013.38","volume":"33","author":"C Ayata","year":"2013","unstructured":"Ayata C, Shin HK, Dilekoz E, Atochin DN, Kashiwagi S, Eikermann-Haerter K, Huang PL (2013) Hyperlipidemia disrupts cerebrovascular reflexes and worsens ischemic perfusion defect. J Cereb Blood Flow Metab 33(6):954\u2013962. https:\/\/doi.org\/10.1038\/jcbfm.2013.38","journal-title":"J Cereb Blood Flow Metab"},{"key":"4797_CR68","doi-asserted-by":"publisher","first-page":"4125731","DOI":"10.1155\/2016\/4125731","volume":"2016","author":"M Chen","year":"2016","unstructured":"Chen M, Zheng H, Wei T, Wang D, Xia H, Zhao L, Ji J, Gao H (2016) High glucose-induced PC12 cell death by increasing glutamate production and decreasing methyl group metabolism. Biomed Res Int 2016:4125731. https:\/\/doi.org\/10.1155\/2016\/4125731","journal-title":"Biomed Res Int"},{"issue":"37","key":"4797_CR69","doi-asserted-by":"publisher","first-page":"14393","DOI":"10.1074\/jbc.RA117.001032","volume":"293","author":"Y Huang","year":"2018","unstructured":"Huang Y, Leng TD, Inoue K, Yang T, Liu M, Horgen FD, Fleig A, Li J et al (2018) TRPM7 channels play a role in high glucose-induced endoplasmic reticulum stress and neuronal cell apoptosis. J Biol Chem 293(37):14393\u201314406. https:\/\/doi.org\/10.1074\/jbc.RA117.001032","journal-title":"J Biol Chem"},{"key":"4797_CR70","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.ibneur.2022.12.006","volume":"14","author":"M Gupta","year":"2023","unstructured":"Gupta M, Pandey S, Rumman M, Singh B, Mahdi AA (2023) Molecular mechanisms underlying hyperglycemia associated cognitive decline. IBRO Neurosci Rep 14:57\u201363. https:\/\/doi.org\/10.1016\/j.ibneur.2022.12.006","journal-title":"IBRO Neurosci Rep"},{"issue":"1","key":"4797_CR71","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s40035-022-00288-z","volume":"11","author":"YQ Lv","year":"2022","unstructured":"Lv YQ, Yuan L, Sun Y, Dou HW, Su JH, Hou ZP, Li JY, Li W (2022) Long-term hyperglycemia aggravates alpha-synuclein aggregation and dopaminergic neuronal loss in a Parkinson\u2019s disease mouse model. Transl Neurodegener 11(1):14. https:\/\/doi.org\/10.1186\/s40035-022-00288-z","journal-title":"Transl Neurodegener"},{"issue":"2","key":"4797_CR72","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1161\/HYPERTENSIONAHA.120.14521","volume":"76","author":"PG Guyenet","year":"2020","unstructured":"Guyenet PG, Stornetta RL, Souza G, Abbott SBG, Brooks VL (2020) Neuronal networks in hypertension: recent advances. Hypertension 76(2):300\u2013311. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.120.14521","journal-title":"Hypertension"},{"issue":"5","key":"4797_CR73","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1161\/01.hyp.36.5.824","volume":"36","author":"MS Rumantir","year":"2000","unstructured":"Rumantir MS, Kaye DM, Jennings GL, Vaz M, Hastings JA, Esler MD (2000) Phenotypic evidence of faulty neuronal norepinephrine reuptake in essential hypertension. Hypertension 36(5):824\u2013829. https:\/\/doi.org\/10.1161\/01.hyp.36.5.824","journal-title":"Hypertension"},{"issue":"2","key":"4797_CR74","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1161\/01.HYP.0000103160.35395.9E","volume":"43","author":"MP Schlaich","year":"2004","unstructured":"Schlaich MP, Lambert E, Kaye DM, Krozowski Z, Campbell DJ, Lambert G, Hastings J, Aggarwal A et al (2004) Sympathetic augmentation in hypertension: role of nerve firing, norepinephrine reuptake, and Angiotensin neuromodulation. Hypertension 43(2):169\u2013175. https:\/\/doi.org\/10.1161\/01.HYP.0000103160.35395.9E","journal-title":"Hypertension"},{"issue":"6 Pt 2","key":"4797_CR75","doi-asserted-by":"publisher","first-page":"99S","DOI":"10.1016\/s0895-7061(00)00225-9","volume":"13","author":"M Esler","year":"2000","unstructured":"Esler M (2000) The sympathetic system and hypertension. Am J Hypertens 13(6 Pt 2):99S-105S. https:\/\/doi.org\/10.1016\/s0895-7061(00)00225-9","journal-title":"Am J Hypertens"},{"issue":"6","key":"4797_CR76","doi-asserted-by":"publisher","first-page":"5497","DOI":"10.3892\/etm.2017.5216","volume":"14","author":"S Liu","year":"2017","unstructured":"Liu S, Yi F, Cheng W, Qu X, Wang C (2017) Molecular mechanisms in vascular injury induced by hypertension: Expression and role of microRNA-34a. Exp Ther Med 14(6):5497\u20135502. https:\/\/doi.org\/10.3892\/etm.2017.5216","journal-title":"Exp Ther Med"},{"issue":"2","key":"4797_CR77","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/nri2921","volume":"11","author":"N Ouchi","year":"2011","unstructured":"Ouchi N, Parker JL, Lugus JJ, Walsh K (2011) Adipokines in inflammation and metabolic disease. Nat Rev Immunol 11(2):85\u201397. https:\/\/doi.org\/10.1038\/nri2921","journal-title":"Nat Rev Immunol"},{"issue":"12","key":"4797_CR78","doi-asserted-by":"publisher","first-page":"3110S","DOI":"10.1093\/jn\/130.12.3110S","volume":"130","author":"S Kim","year":"2000","unstructured":"Kim S, Moustaid-Moussa N (2000) Secretory, endocrine and autocrine\/paracrine function of the adipocyte. J Nutr 130(12):3110S-3115S. https:\/\/doi.org\/10.1093\/jn\/130.12.3110S","journal-title":"J Nutr"},{"issue":"7","key":"4797_CR79","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.tips.2015.04.014","volume":"36","author":"M Fasshauer","year":"2015","unstructured":"Fasshauer M, Bluher M (2015) Adipokines in health and disease. Trends Pharmacol Sci 36(7):461\u2013470. https:\/\/doi.org\/10.1016\/j.tips.2015.04.014","journal-title":"Trends Pharmacol Sci"},{"key":"4797_CR80","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1111\/j.1749-6632.2010.05875.x","volume":"1212","author":"Y Deng","year":"2010","unstructured":"Deng Y, Scherer PE (2010) Adipokines as novel biomarkers and regulators of the metabolic syndrome. Ann N Y Acad Sci 1212:E1\u2013E19. https:\/\/doi.org\/10.1111\/j.1749-6632.2010.05875.x","journal-title":"Ann N Y Acad Sci"},{"key":"4797_CR81","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.cca.2013.02.003","volume":"419","author":"O Leal Vde","year":"2013","unstructured":"Leal Vde O, Mafra D (2013) Adipokines in obesity. Clin Chim Acta 419:87\u201394. https:\/\/doi.org\/10.1016\/j.cca.2013.02.003","journal-title":"Clin Chim Acta"},{"issue":"10","key":"4797_CR82","doi-asserted-by":"publisher","first-page":"3570","DOI":"10.3390\/ijms21103570","volume":"21","author":"K Zorena","year":"2020","unstructured":"Zorena K, Jachimowicz-Duda O, Slezak D, Robakowska M, Mrugacz M (2020) Adipokines and obesity. Potential link to metabolic disorders and chronic complications. Int J Mol Sci 21(10):3570. https:\/\/doi.org\/10.3390\/ijms21103570","journal-title":"Int J Mol Sci"},{"issue":"5","key":"4797_CR83","doi-asserted-by":"publisher","first-page":"497","DOI":"10.3945\/an.114.005934","volume":"5","author":"D Aguilar","year":"2014","unstructured":"Aguilar D, Fernandez ML (2014) Hypercholesterolemia induces adipose dysfunction in conditions of obesity and nonobesity. Adv Nutr 5(5):497\u2013502. https:\/\/doi.org\/10.3945\/an.114.005934","journal-title":"Adv Nutr"},{"issue":"4","key":"4797_CR84","doi-asserted-by":"publisher","first-page":"6184","DOI":"10.3390\/ijms15046184","volume":"15","author":"UJ Jung","year":"2014","unstructured":"Jung UJ, Choi MS (2014) Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease. Int J Mol Sci 15(4):6184\u20136223. https:\/\/doi.org\/10.3390\/ijms15046184","journal-title":"Int J Mol Sci"},{"key":"4797_CR85","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.metabol.2018.11.005","volume":"92","author":"J Vekic","year":"2019","unstructured":"Vekic J, Zeljkovic A, Stefanovic A, Jelic-Ivanovic Z, Spasojevic-Kalimanovska V (2019) Obesity and dyslipidemia. Metabolism 92:71\u201381. https:\/\/doi.org\/10.1016\/j.metabol.2018.11.005","journal-title":"Metabolism"},{"issue":"1 Suppl 1","key":"4797_CR86","doi-asserted-by":"publisher","first-page":"S60","DOI":"10.1016\/j.dsx.2015.09.015","volume":"10","author":"M Rahimlou","year":"2016","unstructured":"Rahimlou M, Mirzaei K, Keshavarz SA, Hossein-Nezhad A (2016) Association of circulating adipokines with metabolic dyslipidemia in obese versus non-obese individuals. Diabetes Metab Syndr 10(1 Suppl 1):S60-65. https:\/\/doi.org\/10.1016\/j.dsx.2015.09.015","journal-title":"Diabetes Metab Syndr"},{"issue":"1","key":"4797_CR87","doi-asserted-by":"publisher","first-page":"8918","DOI":"10.1038\/s41598-019-45509-0","volume":"9","author":"M Wang","year":"2019","unstructured":"Wang M, Jo J, Song J (2019) Adiponectin improves long-term potentiation in the 5XFAD mouse brain. Sci Rep 9(1):8918. https:\/\/doi.org\/10.1038\/s41598-019-45509-0","journal-title":"Sci Rep"},{"issue":"4","key":"4797_CR88","doi-asserted-by":"publisher","first-page":"4095","DOI":"10.3892\/mmr.2018.9389","volume":"18","author":"EC Feng","year":"2018","unstructured":"Feng EC, Jiang L (2018) Effects of leptin on neurocognitive and motor functions in juvenile rats in a preterm brain damage model. Mol Med Rep 18(4):4095\u20134102. https:\/\/doi.org\/10.3892\/mmr.2018.9389","journal-title":"Mol Med Rep"},{"issue":"5","key":"4797_CR89","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.bbadis.2008.12.004","volume":"1792","author":"CD Morrison","year":"2009","unstructured":"Morrison CD (2009) Leptin signaling in brain: A link between nutrition and cognition? Biochim Biophys Acta 1792(5):401\u2013408. https:\/\/doi.org\/10.1016\/j.bbadis.2008.12.004","journal-title":"Biochim Biophys Acta"},{"key":"4797_CR90","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.npep.2014.12.004","volume":"49","author":"S Erfani","year":"2015","unstructured":"Erfani S, Khaksari M, Oryan S, Shamsaei N, Aboutaleb N, Nikbakht F, Jamali-Raeufy N, Gorjipour F (2015) Visfatin reduces hippocampal CA1 cells death and improves learning and memory deficits after transient global ischemia\/reperfusion. Neuropeptides 49:63\u201368. https:\/\/doi.org\/10.1016\/j.npep.2014.12.004","journal-title":"Neuropeptides"},{"issue":"1","key":"4797_CR91","doi-asserted-by":"publisher","first-page":"e15981","DOI":"10.1371\/journal.pone.0015981","volume":"6","author":"BS Park","year":"2011","unstructured":"Park BS, Jin SH, Park JJ, Park JW, Namgoong IS, Kim YI, Lee BJ, Kim JG (2011) Visfatin induces sickness responses in the brain. PLoS ONE 6(1):e15981. https:\/\/doi.org\/10.1371\/journal.pone.0015981","journal-title":"PLoS ONE"},{"issue":"6818","key":"4797_CR92","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/35053000","volume":"409","author":"CM Steppan","year":"2001","unstructured":"Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, Patel HR, Ahima RS et al (2001) The hormone resistin links obesity to diabetes. Nature 409(6818):307\u2013312. https:\/\/doi.org\/10.1038\/35053000","journal-title":"Nature"},{"key":"4797_CR93","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/s12967-015-0574-1","volume":"13","author":"R Pullerits","year":"2015","unstructured":"Pullerits R, Oltean S, Floden A, Oltean M (2015) Circulating resistin levels are early and significantly increased in deceased brain dead organ donors, correlate with inflammatory cytokine response and remain unaffected by steroid treatment. J Transl Med 13:201. https:\/\/doi.org\/10.1186\/s12967-015-0574-1","journal-title":"J Transl Med"},{"issue":"5","key":"4797_CR94","doi-asserted-by":"publisher","first-page":"R190","DOI":"10.1186\/cc9307","volume":"14","author":"XQ Dong","year":"2010","unstructured":"Dong XQ, Yang SB, Zhu FL, Lv QW, Zhang GH, Huang HB (2010) Resistin is associated with mortality in patients with traumatic brain injury. Crit Care 14(5):R190. https:\/\/doi.org\/10.1186\/cc9307","journal-title":"Crit Care"},{"issue":"1","key":"4797_CR95","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1530\/JOE-18-0096","volume":"238","author":"J Miao","year":"2018","unstructured":"Miao J, Benomar Y, Al Rifai S, Poizat G, Riffault L, Crepin D, Taouis M (2018) Resistin inhibits neuronal autophagy through Toll-like receptor 4. J Endocrinol 238(1):77\u201389. https:\/\/doi.org\/10.1530\/JOE-18-0096","journal-title":"J Endocrinol"},{"issue":"1","key":"4797_CR96","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/2047-783X-18-12","volume":"18","author":"EA Al-Suhaimi","year":"2013","unstructured":"Al-Suhaimi EA, Shehzad A (2013) Leptin, resistin and visfatin: the missing link between endocrine metabolic disorders and immunity. Eur J Med Res 18(1):12. https:\/\/doi.org\/10.1186\/2047-783X-18-12","journal-title":"Eur J Med Res"},{"key":"4797_CR97","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.atherosclerosis.2015.10.100","volume":"244","author":"CH Saely","year":"2016","unstructured":"Saely CH, Leiherer A, Muendlein A, Vonbank A, Rein P, Geiger K, Malin C, Drexel H (2016) High plasma omentin predicts cardiovascular events independently from the presence and extent of angiographically determined atherosclerosis. Atherosclerosis 244:38\u201343. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2015.10.100","journal-title":"Atherosclerosis"},{"issue":"6","key":"4797_CR98","doi-asserted-by":"publisher","first-page":"e79","DOI":"10.2337\/dc15-2702","volume":"39","author":"C Wittenbecher","year":"2016","unstructured":"Wittenbecher C, Menzel J, Carstensen-Kirberg M, Biemann R, di Giuseppe R, Fritsche A, Isermann B, Herder C et al (2016) Omentin-1, adiponectin, and the risk of developing type 2 diabetes. Diabetes Care 39(6):e79-80. https:\/\/doi.org\/10.2337\/dc15-2702","journal-title":"Diabetes Care"},{"issue":"3","key":"4797_CR99","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.3892\/mmr.2014.2937","volume":"11","author":"LR Zhao","year":"2015","unstructured":"Zhao LR, Du YJ, Chen L, Liu ZG, Jia XY, Pan YH, Liu JF, Liu B (2015) Omentin-1 promotes the growth of neural stem cells via activation of Akt signaling. Mol Med Rep 11(3):1859\u20131864. https:\/\/doi.org\/10.3892\/mmr.2014.2937","journal-title":"Mol Med Rep"},{"issue":"3","key":"4797_CR100","doi-asserted-by":"publisher","first-page":"384","DOI":"10.3390\/metabo13030384","volume":"13","author":"A Al-Sayyar","year":"2023","unstructured":"Al-Sayyar A, Hammad MM, Williams MR, Al-Onaizi M, Abubaker J, Alzaid F (2023) Neurotransmitters in type 2 diabetes and the control of systemic and central energy balance. Metabolites 13(3):384. https:\/\/doi.org\/10.3390\/metabo13030384","journal-title":"Metabolites"},{"key":"4797_CR101","doi-asserted-by":"publisher","first-page":"827541","DOI":"10.3389\/fpsyt.2021.827541","volume":"12","author":"M Li","year":"2021","unstructured":"Li M, Cui J, Xu B, Wei Y, Fu C, Lv X, Xiong L, Qin D (2021) Sleep disturbances and depression are Co-morbid conditions: insights from animal models, especially non-human primate model. Front Psychiatry 12:827541. https:\/\/doi.org\/10.3389\/fpsyt.2021.827541","journal-title":"Front Psychiatry"},{"issue":"5","key":"4797_CR102","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.nut.2009.09.020","volume":"26","author":"UN Das","year":"2010","unstructured":"Das UN (2010) Obesity: genes, brain, gut, and environment. Nutrition 26(5):459\u2013473. https:\/\/doi.org\/10.1016\/j.nut.2009.09.020","journal-title":"Nutrition"},{"key":"4797_CR103","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s40659-016-0075-6","volume":"49","author":"C Sandoval-Salazar","year":"2016","unstructured":"Sandoval-Salazar C, Ramirez-Emiliano J, Trejo-Bahena A, Oviedo-Solis CI, Solis-Ortiz MS (2016) A high-fat diet decreases GABA concentration in the frontal cortex and hippocampus of rats. Biol Res 49:15. https:\/\/doi.org\/10.1186\/s40659-016-0075-6","journal-title":"Biol Res"},{"issue":"6","key":"4797_CR104","doi-asserted-by":"publisher","first-page":"476","DOI":"10.4062\/biomolther.2013.063","volume":"21","author":"M Kim","year":"2013","unstructured":"Kim M, Bae S, Lim KM (2013) Impact of high fat diet-induced obesity on the plasma levels of monoamine neurotransmitters in C57BL\/6 Mice. Biomol Ther (Seoul) 21(6):476\u2013480. https:\/\/doi.org\/10.4062\/biomolther.2013.063","journal-title":"Biomol Ther (Seoul)"},{"issue":"9","key":"4797_CR105","doi-asserted-by":"publisher","first-page":"3959","DOI":"10.1523\/JNEUROSCI.4744-14.2015","volume":"35","author":"HK Karlsson","year":"2015","unstructured":"Karlsson HK, Tuominen L, Tuulari JJ, Hirvonen J, Parkkola R, Helin S, Salminen P, Nuutila P et al (2015) Obesity is associated with decreased mu-opioid but unaltered dopamine D2 receptor availability in the brain. J Neurosci 35(9):3959\u20133965. https:\/\/doi.org\/10.1523\/JNEUROSCI.4744-14.2015","journal-title":"J Neurosci"},{"issue":"5","key":"4797_CR106","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1080\/1028415021000033785","volume":"5","author":"F Svec","year":"2002","unstructured":"Svec F, Thompson H, Corll C, Porter J (2002) Levels of hypothalamic neurotransmitters in lean and obese Zucker rats. Nutr Neurosci 5(5):321\u2013326. https:\/\/doi.org\/10.1080\/1028415021000033785","journal-title":"Nutr Neurosci"},{"issue":"2","key":"4797_CR107","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1093\/ajh\/hps016","volume":"26","author":"E Lambert","year":"2013","unstructured":"Lambert E, Straznicky N, Sari CI, Eikelis N, Hering D, Head G, Dixon J, Esler M et al (2013) Dyslipidemia is associated with sympathetic nervous activation and impaired endothelial function in young females. Am J Hypertens 26(2):250\u2013256. https:\/\/doi.org\/10.1093\/ajh\/hps016","journal-title":"Am J Hypertens"},{"issue":"1","key":"4797_CR108","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1080\/08037050310028471","volume":"13","author":"K Atarashi","year":"2004","unstructured":"Atarashi K, Ishiyama A, Minami M, Takagi M, Omata M (2004) Effects of acute hypercholesterolemia on blood pressure and pressor response to norepinephrine in rats. Blood Press 13(1):56\u201361. https:\/\/doi.org\/10.1080\/08037050310028471","journal-title":"Blood Press"},{"key":"4797_CR109","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.neuint.2017.01.021","volume":"108","author":"R Paul","year":"2017","unstructured":"Paul R, Choudhury A, Chandra Boruah D, Devi R, Bhattacharya P, Choudhury MD, Borah A (2017) Hypercholesterolemia causes psychomotor abnormalities in mice and alterations in cortico-striatal biogenic amine neurotransmitters: Relevance to Parkinson\u2019s disease. Neurochem Int 108:15\u201326. https:\/\/doi.org\/10.1016\/j.neuint.2017.01.021","journal-title":"Neurochem Int"},{"key":"4797_CR110","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.bbr.2016.05.029","volume":"311","author":"DF Engel","year":"2016","unstructured":"Engel DF, de Oliveira J, Lopes JB, Santos DB, Moreira ELG, Farina M, Rodrigues ALS, de Souza BP et al (2016) Is there an association between hypercholesterolemia and depression? Behavioral evidence from the LDLr(-\/-) mouse experimental model. Behav Brain Res 311:31\u201338. https:\/\/doi.org\/10.1016\/j.bbr.2016.05.029","journal-title":"Behav Brain Res"},{"issue":"1\u20132","key":"4797_CR111","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1159\/000501023","volume":"110","author":"DS Razolli","year":"2020","unstructured":"Razolli DS, de Araujo TM, Sant Apos Ana MR, Kirwan P, Cintra DE, Merkle FT, Velloso LA (2020) Proopiomelanocortin processing in the hypothalamus is directly regulated by saturated fat: implications for the development of obesity. Neuroendocrinology 110(1\u20132):92\u2013104. https:\/\/doi.org\/10.1159\/000501023","journal-title":"Neuroendocrinology"},{"issue":"7","key":"4797_CR112","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1038\/nm1611","volume":"13","author":"LE Kuo","year":"2007","unstructured":"Kuo LE, Kitlinska JB, Tilan JU, Li L, Baker SB, Johnson MD, Lee EW, Burnett MS et al (2007) Neuropeptide Y acts directly in the periphery on fat tissue and mediates stress-induced obesity and metabolic syndrome. Nat Med 13(7):803\u2013811. https:\/\/doi.org\/10.1038\/nm1611","journal-title":"Nat Med"},{"key":"4797_CR113","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.physbeh.2016.04.049","volume":"162","author":"MC Gumbs","year":"2016","unstructured":"Gumbs MC, van den Heuvel JK, la Fleur SE (2016) The effect of obesogenic diets on brain Neuropeptide Y. Physiol Behav 162:161\u2013173. https:\/\/doi.org\/10.1016\/j.physbeh.2016.04.049","journal-title":"Physiol Behav"},{"issue":"7","key":"4797_CR114","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1001\/archpsyc.63.7.824","volume":"63","author":"GE Simon","year":"2006","unstructured":"Simon GE, Von Korff M, Saunders K, Miglioretti DL, Crane PK, van Belle G, Kessler RC (2006) Association between obesity and psychiatric disorders in the US adult population. Arch Gen Psychiatry 63(7):824\u2013830. https:\/\/doi.org\/10.1001\/archpsyc.63.7.824","journal-title":"Arch Gen Psychiatry"},{"issue":"Suppl 1","key":"4797_CR115","doi-asserted-by":"publisher","first-page":"S28","DOI":"10.1016\/j.freeradbiomed.2014.10.753","volume":"75","author":"A De Bem","year":"2014","unstructured":"De Bem A, Engel D, de Oliveira J, Moreira EL, Neis VB, Santos DB, Lopes JB, Rodrigues AL et al (2014) Hypercholesterolemia as a risk factor for depressive disorder? Free Radic Biol Med 75(Suppl 1):S28. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2014.10.753","journal-title":"Free Radic Biol Med"},{"key":"4797_CR116","doi-asserted-by":"publisher","first-page":"810","DOI":"10.3389\/fcell.2020.00810","volume":"8","author":"C Ripoli","year":"2020","unstructured":"Ripoli C, Spinelli M, Natale F, Fusco S, Grassi C (2020) Glucose overload inhibits glutamatergic synaptic transmission: a novel role for CREB-mediated regulation of synaptotagmins 2 and 4. Front Cell Dev Biol 8:810. https:\/\/doi.org\/10.3389\/fcell.2020.00810","journal-title":"Front Cell Dev Biol"},{"issue":"7","key":"4797_CR117","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.2337\/db19-0936","volume":"69","author":"NR Bolo","year":"2020","unstructured":"Bolo NR, Jacobson AM, Musen G, Keshavan MS, Simonson DC (2020) Acute hyperglycemia increases brain pregenual anterior cingulate cortex glutamate concentrations in type 1 diabetes. Diabetes 69(7):1528\u20131539. https:\/\/doi.org\/10.2337\/db19-0936","journal-title":"Diabetes"},{"issue":"1","key":"4797_CR118","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1161\/01.str.31.1.183","volume":"31","author":"PA Li","year":"2000","unstructured":"Li PA, Shuaib A, Miyashita H, He QP, Siesjo BK, Warner DS (2000) Hyperglycemia enhances extracellular glutamate accumulation in rats subjected to forebrain ischemia. Stroke 31(1):183\u2013192. https:\/\/doi.org\/10.1161\/01.str.31.1.183","journal-title":"Stroke"},{"key":"4797_CR119","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.bbrc.2021.11.108","volume":"589","author":"S Sasaki-Hamada","year":"2022","unstructured":"Sasaki-Hamada S, Sanai E, Kanemaru M, Kamanaka G, Oka JI (2022) Long-term exposure to high glucose induces changes in the expression of AMPA receptor subunits and glutamate transmission in primary cultured cortical neurons. Biochem Biophys Res Commun 589:48\u201354. https:\/\/doi.org\/10.1016\/j.bbrc.2021.11.108","journal-title":"Biochem Biophys Res Commun"},{"issue":"9","key":"4797_CR120","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1002\/mds.28124","volume":"35","author":"I Perez-Taboada","year":"2020","unstructured":"Perez-Taboada I, Alberquilla S, Martin ED, Anand R, Vietti-Michelina S, Tebeka NN, Cantley J, Cragg SJ et al (2020) Diabetes causes dysfunctional dopamine neurotransmission favoring nigrostriatal degeneration in mice. Mov Disord 35(9):1636\u20131648. https:\/\/doi.org\/10.1002\/mds.28124","journal-title":"Mov Disord"},{"issue":"36","key":"4797_CR121","doi-asserted-by":"publisher","first-page":"32339","DOI":"10.1021\/acsomega.2c03384","volume":"7","author":"ACV de Guzman","year":"2022","unstructured":"de Guzman ACV, Kang S, Kim EJ, Kim JH, Jang N, Cho JH, Choi SS (2022) High-glucose diet attenuates the dopaminergic neuronal function in C. elegans, leading to the acceleration of the aging process. ACS Omega 7(36):32339\u201332348. https:\/\/doi.org\/10.1021\/acsomega.2c03384","journal-title":"ACS Omega"},{"issue":"24","key":"4797_CR122","doi-asserted-by":"publisher","first-page":"4012","DOI":"10.3390\/cells11244012","volume":"11","author":"JH Baek","year":"2022","unstructured":"Baek JH, Son H, Kang JS, Yoo DY, Chung HJ, Lee DK, Kim HJ (2022) Long-term hyperglycemia causes depressive behaviors in mice with hypoactive glutamatergic activity in the medial prefrontal cortex, which is not reversed by insulin treatment. Cells 11(24):4012. https:\/\/doi.org\/10.3390\/cells11244012","journal-title":"Cells"},{"issue":"6","key":"4797_CR123","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1111\/j.1471-4159.2005.03155.x","volume":"93","author":"JG Mielke","year":"2005","unstructured":"Mielke JG, Taghibiglou C, Liu L, Zhang Y, Jia Z, Adeli K, Wang YT (2005) A biochemical and functional characterization of diet-induced brain insulin resistance. J Neurochem 93(6):1568\u20131578. https:\/\/doi.org\/10.1111\/j.1471-4159.2005.03155.x","journal-title":"J Neurochem"},{"key":"4797_CR124","doi-asserted-by":"publisher","first-page":"601939","DOI":"10.3389\/fnbeh.2020.601939","volume":"14","author":"JA Sheng","year":"2020","unstructured":"Sheng JA, Bales NJ, Myers SA, Bautista AI, Roueinfar M, Hale TM, Handa RJ (2020) The hypothalamic-pituitary-adrenal axis: development, programming actions of hormones, and maternal-fetal interactions. Front Behav Neurosci 14:601939. https:\/\/doi.org\/10.3389\/fnbeh.2020.601939","journal-title":"Front Behav Neurosci"},{"key":"4797_CR125","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.psyneuen.2015.08.014","volume":"62","author":"AC Incollingo Rodriguez","year":"2015","unstructured":"Incollingo Rodriguez AC, Epel ES, White ML, Standen EC, Seckl JR, Tomiyama AJ (2015) Hypothalamic-pituitary-adrenal axis dysregulation and cortisol activity in obesity: A systematic review. Psychoneuroendocrinology 62:301\u2013318. https:\/\/doi.org\/10.1016\/j.psyneuen.2015.08.014","journal-title":"Psychoneuroendocrinology"},{"key":"4797_CR126","doi-asserted-by":"publisher","first-page":"748048","DOI":"10.1155\/2010\/748048","volume":"2010","author":"VH Taylor","year":"2010","unstructured":"Taylor VH, Macqueen GM (2010) The role of adipokines in understanding the associations between obesity and depression. J Obes 2010:748048. https:\/\/doi.org\/10.1155\/2010\/748048","journal-title":"J Obes"},{"issue":"5","key":"4797_CR127","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1080\/10253890.2018.1470238","volume":"21","author":"JK Gjerstad","year":"2018","unstructured":"Gjerstad JK, Lightman SL, Spiga F (2018) Role of glucocorticoid negative feedback in the regulation of HPA axis pulsatility. Stress 21(5):403\u2013416. https:\/\/doi.org\/10.1080\/10253890.2018.1470238","journal-title":"Stress"},{"key":"4797_CR128","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.3389\/fimmu.2019.01545","volume":"10","author":"S Timmermans","year":"2019","unstructured":"Timmermans S, Souffriau J, Libert C (2019) A General Introduction to Glucocorticoid Biology. Front Immunol 10:1545. https:\/\/doi.org\/10.3389\/fimmu.2019.01545","journal-title":"Front Immunol"},{"key":"4797_CR129","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ibror.2018.11.008","volume":"6","author":"AM Bao","year":"2019","unstructured":"Bao AM, Swaab DF (2019) The human hypothalamus in mood disorders: The HPA axis in the center. IBRO Rep 6:45\u201353. https:\/\/doi.org\/10.1016\/j.ibror.2018.11.008","journal-title":"IBRO Rep"},{"key":"4797_CR130","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3389\/fncel.2012.00024","volume":"6","author":"BH Levy","year":"2012","unstructured":"Levy BH, Tasker JG (2012) Synaptic regulation of the hypothalamic-pituitary-adrenal axis and its modulation by glucocorticoids and stress. Front Cell Neurosci 6:24. https:\/\/doi.org\/10.3389\/fncel.2012.00024","journal-title":"Front Cell Neurosci"},{"issue":"10","key":"4797_CR131","doi-asserted-by":"publisher","first-page":"3572","DOI":"10.1523\/JNEUROSCI.21-10-03572.2001","volume":"21","author":"LD Van de Kar","year":"2001","unstructured":"Van de Kar LD, Javed A, Zhang Y, Serres F, Raap DK, Gray TS (2001) 5-HT2A receptors stimulate ACTH, corticosterone, oxytocin, renin, and prolactin release and activate hypothalamic CRF and oxytocin-expressing cells. J Neurosci 21(10):3572\u20133579. https:\/\/doi.org\/10.1523\/JNEUROSCI.21-10-03572.2001","journal-title":"J Neurosci"},{"issue":"26","key":"4797_CR132","doi-asserted-by":"publisher","first-page":"6956","DOI":"10.1523\/JNEUROSCI.2584-06.2007","volume":"27","author":"LK Heisler","year":"2007","unstructured":"Heisler LK, Pronchuk N, Nonogaki K, Zhou L, Raber J, Tung L, Yeo GS, O\u2019Rahilly S et al (2007) Serotonin activates the hypothalamic-pituitary-adrenal axis via serotonin 2C receptor stimulation. J Neurosci 27(26):6956\u20136964. https:\/\/doi.org\/10.1523\/JNEUROSCI.2584-06.2007","journal-title":"J Neurosci"},{"issue":"3","key":"4797_CR133","doi-asserted-by":"publisher","first-page":"111509","DOI":"10.1016\/j.celrep.2022.111509","volume":"41","author":"Z Jiang","year":"2022","unstructured":"Jiang Z, Chen C, Weiss GL, Fu X, Stelly CE, Sweeten BLW, Tirrell PS, Pursell I et al (2022) Stress-induced glucocorticoid desensitizes adrenoreceptors to gate the neuroendocrine response to somatic stress in male mice. Cell Rep 41(3):111509. https:\/\/doi.org\/10.1016\/j.celrep.2022.111509","journal-title":"Cell Rep"},{"issue":"11","key":"4797_CR134","doi-asserted-by":"publisher","first-page":"2825","DOI":"10.1523\/JNEUROSCI.3422-03.2004","volume":"24","author":"JC Pruessner","year":"2004","unstructured":"Pruessner JC, Champagne F, Meaney MJ, Dagher A (2004) Dopamine release in response to a psychological stress in humans and its relationship to early life maternal care: a positron emission tomography study using [11C]raclopride. J Neurosci 24(11):2825\u20132831. https:\/\/doi.org\/10.1523\/JNEUROSCI.3422-03.2004","journal-title":"J Neurosci"},{"key":"4797_CR135","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1196\/annals.1296.004","volume":"1018","author":"JP Herman","year":"2004","unstructured":"Herman JP, Mueller NK, Figueiredo H (2004) Role of GABA and glutamate circuitry in hypothalamo-pituitary-adrenocortical stress integration. Ann N Y Acad Sci 1018:35\u201345. https:\/\/doi.org\/10.1196\/annals.1296.004","journal-title":"Ann N Y Acad Sci"},{"key":"4797_CR136","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1196\/annals.1410.044","volume":"1148","author":"JD Mikkelsen","year":"2008","unstructured":"Mikkelsen JD, Bundzikova J, Larsen MH, Hansen HH, Kiss A (2008) GABA regulates the rat hypothalamic-pituitary-adrenocortical axis via different GABA-A receptor alpha-subtypes. Ann N Y Acad Sci 1148:384\u2013392. https:\/\/doi.org\/10.1196\/annals.1410.044","journal-title":"Ann N Y Acad Sci"},{"issue":"1\u20132","key":"4797_CR137","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.mce.2013.12.007","volume":"383","author":"M Chen","year":"2014","unstructured":"Chen M, Wang Z, Zhan M, Liu R, Nie A, Wang J, Ning G, Ma Q (2014) Adiponectin regulates ACTH secretion and the HPAA in an AMPK-dependent manner in pituitary corticotroph cells. Mol Cell Endocrinol 383(1\u20132):118\u2013125. https:\/\/doi.org\/10.1016\/j.mce.2013.12.007","journal-title":"Mol Cell Endocrinol"},{"issue":"5","key":"4797_CR138","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1056\/NEJM199602013340503","volume":"334","author":"RV Considine","year":"1996","unstructured":"Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC et al (1996) Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 334(5):292\u2013295. https:\/\/doi.org\/10.1056\/NEJM199602013340503","journal-title":"N Engl J Med"},{"issue":"9","key":"4797_CR139","doi-asserted-by":"publisher","first-page":"3859","DOI":"10.1210\/endo.138.9.5366","volume":"138","author":"ML Heiman","year":"1997","unstructured":"Heiman ML, Ahima RS, Craft LS, Schoner B, Stephens TW, Flier JS (1997) Leptin inhibition of the hypothalamic-pituitary-adrenal axis in response to stress. Endocrinology 138(9):3859\u20133863. https:\/\/doi.org\/10.1210\/endo.138.9.5366","journal-title":"Endocrinology"},{"issue":"8","key":"4797_CR140","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1530\/EC-17-0212","volume":"6","author":"I Azzam","year":"2017","unstructured":"Azzam I, Gilad S, Limor R, Stern N, Greenman Y (2017) Ghrelin stimulation by hypothalamic-pituitary-adrenal axis activation depends on increasing cortisol levels. Endocr Connect 6(8):847\u2013855. https:\/\/doi.org\/10.1530\/EC-17-0212","journal-title":"Endocr Connect"},{"key":"4797_CR141","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.psyneuen.2014.11.013","volume":"52","author":"DA Wittekind","year":"2015","unstructured":"Wittekind DA, Kluge M (2015) Ghrelin in psychiatric disorders - A review. Psychoneuroendocrinology 52:176\u2013194. https:\/\/doi.org\/10.1016\/j.psyneuen.2014.11.013","journal-title":"Psychoneuroendocrinology"},{"issue":"6","key":"4797_CR142","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1080\/17446651.2018.1543585","volume":"13","author":"P Papargyri","year":"2018","unstructured":"Papargyri P, Zapanti E, Salakos N, Papargyris L, Bargiota A, Mastorakos G (2018) Links between HPA axis and adipokines: clinical implications in paradigms of stress-related disorders. Expert Rev Endocrinol Metab 13(6):317\u2013332. https:\/\/doi.org\/10.1080\/17446651.2018.1543585","journal-title":"Expert Rev Endocrinol Metab"},{"issue":"6","key":"4797_CR143","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1017\/S0033291721001185","volume":"51","author":"DJ Stein","year":"2021","unstructured":"Stein DJ, Palk AC, Kendler KS (2021) What is a mental disorder? An exemplar-focused approach. Psychol Med 51(6):894\u2013901. https:\/\/doi.org\/10.1017\/S0033291721001185","journal-title":"Psychol Med"},{"issue":"23","key":"4797_CR144","doi-asserted-by":"publisher","first-page":"5393","DOI":"10.1111\/bph.14949","volume":"177","author":"H Li","year":"2020","unstructured":"Li H, Kilgallen AB, Munzel T, Wolf E, Lecour S, Schulz R, Daiber A, Van Laake LW (2020) Influence of mental stress and environmental toxins on circadian clocks: Implications for redox regulation of the heart and cardioprotection. Br J Pharmacol 177(23):5393\u20135412. https:\/\/doi.org\/10.1111\/bph.14949","journal-title":"Br J Pharmacol"},{"issue":"9","key":"4797_CR145","doi-asserted-by":"publisher","first-page":"4839","DOI":"10.1038\/s41380-020-0774-9","volume":"26","author":"N Opel","year":"2021","unstructured":"Opel N, Thalamuthu A, Milaneschi Y, Grotegerd D, Flint C, Leenings R, Goltermann J, Richter M et al (2021) Brain structural abnormalities in obesity: relation to age, genetic risk, and common psychiatric disorders\u202f: Evidence through univariate and multivariate mega-analysis including 6420 participants from the ENIGMA MDD working group. Mol Psychiatry 26(9):4839\u20134852. https:\/\/doi.org\/10.1038\/s41380-020-0774-9","journal-title":"Mol Psychiatry"},{"key":"4797_CR146","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jpsychires.2018.02.012","volume":"99","author":"M Kolenic","year":"2018","unstructured":"Kolenic M, Franke K, Hlinka J, Matejka M, Capkova J, Pausova Z, Uher R, Alda M et al (2018) Obesity, dyslipidemia and brain age in first-episode psychosis. J Psychiatr Res 99:151\u2013158. https:\/\/doi.org\/10.1016\/j.jpsychires.2018.02.012","journal-title":"J Psychiatr Res"},{"issue":"1","key":"4797_CR147","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.brainresrev.2008.06.003","volume":"59","author":"T Melcher","year":"2008","unstructured":"Melcher T, Falkai P, Gruber O (2008) Functional brain abnormalities in psychiatric disorders: neural mechanisms to detect and resolve cognitive conflict and interference. Brain Res Rev 59(1):96\u2013124. https:\/\/doi.org\/10.1016\/j.brainresrev.2008.06.003","journal-title":"Brain Res Rev"},{"issue":"2","key":"4797_CR148","doi-asserted-by":"publisher","first-page":"57","DOI":"10.5607\/en23010","volume":"32","author":"SY Cheon","year":"2023","unstructured":"Cheon SY (2023) Impaired Cholesterol Metabolism, Neurons, and Neuropsychiatric Disorders. Exp Neurobiol 32(2):57\u201367. https:\/\/doi.org\/10.5607\/en23010","journal-title":"Exp Neurobiol"},{"issue":"3","key":"4797_CR149","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1002\/wps.20771","volume":"19","author":"M Maj","year":"2020","unstructured":"Maj M, Stein DJ, Parker G, Zimmerman M, Fava GA, De Hert M, Demyttenaere K, McIntyre RS et al (2020) The clinical characterization of the adult patient with depression aimed at personalization of management. World Psychiatry 19(3):269\u2013293. https:\/\/doi.org\/10.1002\/wps.20771","journal-title":"World Psychiatry"},{"issue":"Suppl E1","key":"4797_CR150","first-page":"4","volume":"69","author":"DJ Nutt","year":"2008","unstructured":"Nutt DJ (2008) Relationship of neurotransmitters to the symptoms of major depressive disorder. J Clin Psychiatry 69(Suppl E1):4\u20137","journal-title":"J Clin Psychiatry"},{"issue":"3","key":"4797_CR151","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1001\/archpsyc.64.3.327","volume":"64","author":"BW Dunlop","year":"2007","unstructured":"Dunlop BW, Nemeroff CB (2007) The role of dopamine in the pathophysiology of depression. Arch Gen Psychiatry 64(3):327\u2013337. https:\/\/doi.org\/10.1001\/archpsyc.64.3.327","journal-title":"Arch Gen Psychiatry"},{"issue":"2","key":"4797_CR152","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1093\/clinchem\/40.2.288","volume":"40","author":"MJ Owens","year":"1994","unstructured":"Owens MJ, Nemeroff CB (1994) Role of serotonin in the pathophysiology of depression: focus on the serotonin transporter. Clin Chem 40(2):288\u2013295","journal-title":"Clin Chem"},{"issue":"8","key":"4797_CR153","doi-asserted-by":"publisher","first-page":"3243","DOI":"10.1038\/s41380-022-01661-0","volume":"28","author":"J Moncrieff","year":"2023","unstructured":"Moncrieff J, Cooper RE, Stockmann T, Amendola S, Hengartner MP, Horowitz MA (2023) The serotonin theory of depression: a systematic umbrella review of the evidence. Mol Psychiatry 28(8):3243\u20133256. https:\/\/doi.org\/10.1038\/s41380-022-01661-0","journal-title":"Mol Psychiatry"},{"issue":"10","key":"4797_CR154","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1021\/cn500096g","volume":"5","author":"M Angoa-Perez","year":"2014","unstructured":"Angoa-Perez M, Kane MJ, Briggs DI, Herrera-Mundo N, Sykes CE, Francescutti DM, Kuhn DM (2014) Mice genetically depleted of brain serotonin do not display a depression-like behavioral phenotype. ACS Chem Neurosci 5(10):908\u2013919. https:\/\/doi.org\/10.1021\/cn500096g","journal-title":"ACS Chem Neurosci"},{"issue":"1","key":"4797_CR155","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1073\/pnas.97.1.325","volume":"97","author":"ML Wong","year":"2000","unstructured":"Wong ML, Kling MA, Munson PJ, Listwak S, Licinio J, Prolo P, Karp B, McCutcheon IE et al (2000) Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: relation to hypercortisolism and corticotropin-releasing hormone. Proc Natl Acad Sci U S A 97(1):325\u2013330. https:\/\/doi.org\/10.1073\/pnas.97.1.325","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"4797_CR156","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1176\/appi.ajp.2016.15101334","volume":"174","author":"S Moriguchi","year":"2017","unstructured":"Moriguchi S, Yamada M, Takano H, Nagashima T, Takahata K, Yokokawa K, Ito T, Ishii T et al (2017) Norepinephrine transporter in major depressive disorder: A PET study. Am J Psychiatry 174(1):36\u201341. https:\/\/doi.org\/10.1176\/appi.ajp.2016.15101334","journal-title":"Am J Psychiatry"},{"issue":"21","key":"4797_CR157","doi-asserted-by":"publisher","first-page":"8451","DOI":"10.1523\/JNEUROSCI.17-21-08451.1997","volume":"17","author":"V Klimek","year":"1997","unstructured":"Klimek V, Stockmeier C, Overholser J, Meltzer HY, Kalka S, Dilley G, Ordway GA (1997) Reduced levels of norepinephrine transporters in the locus coeruleus in major depression. J Neurosci 17(21):8451\u20138458. https:\/\/doi.org\/10.1523\/JNEUROSCI.17-21-08451.1997","journal-title":"J Neurosci"},{"issue":"6","key":"4797_CR158","doi-asserted-by":"publisher","first-page":"e26523","DOI":"10.5812\/ircmj.26523","volume":"18","author":"R Ghanei Gheshlagh","year":"2016","unstructured":"Ghanei Gheshlagh R, Parizad N, Sayehmiri K (2016) The relationship between depression and metabolic syndrome: systematic review and meta-analysis study. Iran Red Crescent Med J 18(6):e26523. https:\/\/doi.org\/10.5812\/ircmj.26523","journal-title":"Iran Red Crescent Med J"},{"key":"4797_CR159","doi-asserted-by":"publisher","first-page":"101112","DOI":"10.1016\/j.molmet.2020.101112","volume":"43","author":"M Werdermann","year":"2021","unstructured":"Werdermann M, Berger I, Scriba LD, Santambrogio A, Schlinkert P, Brendel H, Morawietz H, Schedl A et al (2021) Insulin and obesity transform hypothalamic-pituitary-adrenal axis stemness and function in a hyperactive state. Mol Metab 43:101112. https:\/\/doi.org\/10.1016\/j.molmet.2020.101112","journal-title":"Mol Metab"},{"issue":"3","key":"4797_CR160","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.metabol.2011.07.009","volume":"61","author":"JB Hillman","year":"2012","unstructured":"Hillman JB, Dorn LD, Loucks TL, Berga SL (2012) Obesity and the hypothalamic-pituitary-adrenal axis in adolescent girls. Metabolism 61(3):341\u2013348. https:\/\/doi.org\/10.1016\/j.metabol.2011.07.009","journal-title":"Metabolism"},{"issue":"17","key":"4797_CR161","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.1001\/archinte.163.17.2058","volume":"163","author":"JB Dixon","year":"2003","unstructured":"Dixon JB, Dixon ME, O\u2019Brien PE (2003) Depression in association with severe obesity: changes with weight loss. Arch Intern Med 163(17):2058\u20132065. https:\/\/doi.org\/10.1001\/archinte.163.17.2058","journal-title":"Arch Intern Med"},{"issue":"6","key":"4797_CR162","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1038\/s41380-020-01004-x","volume":"26","author":"X Fang","year":"2021","unstructured":"Fang X, Jiang S, Wang J, Bai Y, Kim CS, Blake D, Weintraub NL, Lei Y et al (2021) Chronic unpredictable stress induces depression-related behaviors by suppressing AgRP neuron activity. Mol Psychiatry 26(6):2299\u20132315. https:\/\/doi.org\/10.1038\/s41380-020-01004-x","journal-title":"Mol Psychiatry"},{"key":"4797_CR163","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.brainres.2009.09.077","volume":"1314","author":"JC Morales-Medina","year":"2010","unstructured":"Morales-Medina JC, Dumont Y, Quirion R (2010) A possible role of neuropeptide Y in depression and stress. Brain Res 1314:194\u2013205. https:\/\/doi.org\/10.1016\/j.brainres.2009.09.077","journal-title":"Brain Res"},{"issue":"1","key":"4797_CR164","doi-asserted-by":"publisher","first-page":"6190","DOI":"10.1038\/s41598-022-10350-5","volume":"12","author":"AL Han","year":"2022","unstructured":"Han AL (2022) Association between lipid ratio and depression: a cross-sectional study. Sci Rep 12(1):6190. https:\/\/doi.org\/10.1038\/s41598-022-10350-5","journal-title":"Sci Rep"},{"key":"4797_CR165","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.jad.2023.06.017","volume":"338","author":"AF Khalfan","year":"2023","unstructured":"Khalfan AF, Campisi SC, Lo RF, McCrindle BW, Korczak DJ (2023) The association between adolescent depression and dyslipidemia. J Affect Disord 338:239\u2013245. https:\/\/doi.org\/10.1016\/j.jad.2023.06.017","journal-title":"J Affect Disord"},{"issue":"11","key":"4797_CR166","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1007\/s00125-020-05247-9","volume":"63","author":"AFJ Geraets","year":"2020","unstructured":"Geraets AFJ, Kohler S, Muzambi R, Schalkwijk CG, Oenema A, Eussen S, Dagnelie PC, Stehouwer CDA et al (2020) The association of hyperglycaemia and insulin resistance with incident depressive symptoms over 4 years of follow-up: The Maastricht Study. Diabetologia 63(11):2315\u20132328. https:\/\/doi.org\/10.1007\/s00125-020-05247-9","journal-title":"Diabetologia"},{"issue":"1","key":"4797_CR167","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1186\/s12902-022-01147-8","volume":"22","author":"W Yang","year":"2022","unstructured":"Yang W, Liu M, Tian Y, Zhang Q, Zhang J, Chen Q, Suo L, Chen Y (2022) The increased prevalence of depression and anxiety in T2DM patients associated with blood glucose fluctuation and sleep quality. BMC Endocr Disord 22(1):232. https:\/\/doi.org\/10.1186\/s12902-022-01147-8","journal-title":"BMC Endocr Disord"},{"issue":"8","key":"4797_CR168","doi-asserted-by":"publisher","first-page":"e0273327","DOI":"10.1371\/journal.pone.0273327","volume":"17","author":"S Thummasorn","year":"2022","unstructured":"Thummasorn S, Apichai S, Chupradit S, Sirisattayawong P, Chaiwong P, Sriwichaiin S, Pratchayasakul W, Chattipakorn N et al (2022) T2DM patients with depression have higher levels of hyperglycemia and cognitive decline than T2DM patients. PLoS ONE 17(8):e0273327. https:\/\/doi.org\/10.1371\/journal.pone.0273327","journal-title":"PLoS ONE"},{"issue":"9","key":"4797_CR169","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1177\/1359105319876326","volume":"26","author":"TB Gonzalez-Castro","year":"2021","unstructured":"Gonzalez-Castro TB, Escobar-Chan YM, Fresan A, Lopez-Narvaez ML, Tovilla-Zarate CA, Juarez-Rojop IE, Ble-Castillo JL, Genis-Mendoza AD et al (2021) Higher risk of depression in individuals with type 2 diabetes and obesity: Results of a meta-analysis. J Health Psychol 26(9):1404\u20131419. https:\/\/doi.org\/10.1177\/1359105319876326","journal-title":"J Health Psychol"},{"key":"4797_CR170","doi-asserted-by":"publisher","first-page":"100113","DOI":"10.1016\/j.crphar.2022.100113","volume":"3","author":"MV Masule","year":"2022","unstructured":"Masule MV, Rathod S, Agrawal Y, Patil CR, Nakhate KT, Ojha S, Goyal SN, Mahajan UB (2022) Ghrelin mediated regulation of neurosynaptic transmitters in depressive disorders. Curr Res Pharmacol Drug Discov 3:100113. https:\/\/doi.org\/10.1016\/j.crphar.2022.100113","journal-title":"Curr Res Pharmacol Drug Discov"},{"issue":"2","key":"4797_CR171","doi-asserted-by":"publisher","first-page":"103","DOI":"10.5493\/wjem.v5.i2.103","volume":"5","author":"S Zarouna","year":"2015","unstructured":"Zarouna S, Wozniak G, Papachristou AI (2015) Mood disorders: A potential link between ghrelin and leptin on human body? World J Exp Med 5(2):103\u2013109. https:\/\/doi.org\/10.5493\/wjem.v5.i2.103","journal-title":"World J Exp Med"},{"issue":"6","key":"4797_CR172","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.3758\/s13415-018-0626-0","volume":"18","author":"CM Patist","year":"2018","unstructured":"Patist CM, Stapelberg NJC, Du Toit EF, Headrick JP (2018) The brain-adipocyte-gut network: Linking obesity and depression subtypes. Cogn Affect Behav Neurosci 18(6):1121\u20131144. https:\/\/doi.org\/10.3758\/s13415-018-0626-0","journal-title":"Cogn Affect Behav Neurosci"},{"issue":"1","key":"4797_CR173","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2174\/157015909787602779","volume":"7","author":"F Ferrini","year":"2009","unstructured":"Ferrini F, Salio C, Lossi L, Merighi A (2009) Ghrelin in central neurons. Curr Neuropharmacol 7(1):37\u201349. https:\/\/doi.org\/10.2174\/157015909787602779","journal-title":"Curr Neuropharmacol"},{"issue":"4","key":"4797_CR174","doi-asserted-by":"publisher","first-page":"151","DOI":"10.4088\/pcc.v03n0401","volume":"3","author":"FP Varghese","year":"2001","unstructured":"Varghese FP, Brown ES (2001) The hypothalamic-pituitary-adrenal axis in major depressive disorder: A brief primer for primary care physicians. Prim Care Companion J Clin Psychiatry 3(4):151\u2013155. https:\/\/doi.org\/10.4088\/pcc.v03n0401","journal-title":"Prim Care Companion J Clin Psychiatry"},{"issue":"1","key":"4797_CR175","doi-asserted-by":"publisher","first-page":"e12552","DOI":"10.1111\/appy.12552","volume":"16","author":"C Zhang","year":"2024","unstructured":"Zhang C, Dong Y, Li S, Li M, Gao Y, Liu Y, Liu X, Zhou C et al (2024) Ghrelin and depressive symptoms in patients with first-episode drug-naive major depressive disorder: The mediating role of hypothalamic-pituitary-adrenal axis. Asia Pac Psychiatry 16(1):e12552. https:\/\/doi.org\/10.1111\/appy.12552","journal-title":"Asia Pac Psychiatry"},{"issue":"2","key":"4797_CR176","doi-asserted-by":"publisher","first-page":"167","DOI":"10.4306\/pi.2014.11.2.167","volume":"11","author":"S Ozsoy","year":"2014","unstructured":"Ozsoy S, Besirli A, Abdulrezzak U, Basturk M (2014) Serum ghrelin and leptin levels in patients with depression and the effects of treatment. Psychiatry Investig 11(2):167\u2013172. https:\/\/doi.org\/10.4306\/pi.2014.11.2.167","journal-title":"Psychiatry Investig"},{"issue":"3","key":"4797_CR177","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1159\/000339948","volume":"66","author":"Y Ishitobi","year":"2012","unstructured":"Ishitobi Y, Kohno K, Kanehisa M, Inoue A, Imanaga J, Maruyama Y, Ninomiya T, Higuma H et al (2012) Serum ghrelin levels and the effects of antidepressants in major depressive disorder and panic disorder. Neuropsychobiology 66(3):185\u2013192. https:\/\/doi.org\/10.1159\/000339948","journal-title":"Neuropsychobiology"},{"issue":"3","key":"4797_CR178","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.jpsychires.2010.09.002","volume":"45","author":"M Kluge","year":"2011","unstructured":"Kluge M, Schussler P, Dresler M, Schmidt D, Yassouridis A, Uhr M, Steiger A (2011) Effects of ghrelin on psychopathology, sleep and secretion of cortisol and growth hormone in patients with major depression. J Psychiatr Res 45(3):421\u2013426. https:\/\/doi.org\/10.1016\/j.jpsychires.2010.09.002","journal-title":"J Psychiatr Res"},{"issue":"45","key":"4797_CR179","doi-asserted-by":"publisher","first-page":"14057","DOI":"10.1523\/JNEUROSCI.3890-09.2009","volume":"29","author":"ZB Andrews","year":"2009","unstructured":"Andrews ZB, Erion D, Beiler R, Liu ZW, Abizaid A, Zigman J, Elsworth JD, Savitt JM et al (2009) Ghrelin promotes and protects nigrostriatal dopamine function via a UCP2-dependent mitochondrial mechanism. J Neurosci 29(45):14057\u201314065. https:\/\/doi.org\/10.1523\/JNEUROSCI.3890-09.2009","journal-title":"J Neurosci"},{"issue":"1","key":"4797_CR180","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/j.1369-1600.2006.00041.x","volume":"12","author":"E Jerlhag","year":"2007","unstructured":"Jerlhag E, Egecioglu E, Dickson SL, Douhan A, Svensson L, Engel JA (2007) Ghrelin administration into tegmental areas stimulates locomotor activity and increases extracellular concentration of dopamine in the nucleus accumbens. Addict Biol 12(1):6\u201316. https:\/\/doi.org\/10.1111\/j.1369-1600.2006.00041.x","journal-title":"Addict Biol"},{"issue":"2\u20133","key":"4797_CR181","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/s0014-2999(02)02552-9","volume":"454","author":"L Brunetti","year":"2002","unstructured":"Brunetti L, Recinella L, Orlando G, Michelotto B, Di Nisio C, Vacca M (2002) Effects of ghrelin and amylin on dopamine, norepinephrine and serotonin release in the hypothalamus. Eur J Pharmacol 454(2\u20133):189\u2013192. https:\/\/doi.org\/10.1016\/s0014-2999(02)02552-9","journal-title":"Eur J Pharmacol"},{"key":"4797_CR182","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.neuropharm.2013.12.012","volume":"79","author":"C Hansson","year":"2014","unstructured":"Hansson C, Alvarez-Crespo M, Taube M, Skibicka KP, Schmidt L, Karlsson-Lindahl L, Egecioglu E, Nissbrandt H et al (2014) Influence of ghrelin on the central serotonergic signaling system in mice. Neuropharmacology 79:498\u2013505. https:\/\/doi.org\/10.1016\/j.neuropharm.2013.12.012","journal-title":"Neuropharmacology"},{"issue":"4","key":"4797_CR183","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.cmet.2018.02.008","volume":"27","author":"S Yanagi","year":"2018","unstructured":"Yanagi S, Sato T, Kangawa K, Nakazato M (2018) The Homeostatic Force of Ghrelin. Cell Metab 27(4):786\u2013804. https:\/\/doi.org\/10.1016\/j.cmet.2018.02.008","journal-title":"Cell Metab"},{"issue":"1","key":"4797_CR184","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1507\/endocrj.kr-85","volume":"54","author":"H Shimizu","year":"2007","unstructured":"Shimizu H, Oh IS, Okada S, Mori M (2007) Leptin resistance and obesity. Endocr J 54(1):17\u201326. https:\/\/doi.org\/10.1507\/endocrj.kr-85","journal-title":"Endocr J"},{"issue":"1","key":"4797_CR185","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1210\/me.2015-1232","volume":"30","author":"JN Flak","year":"2016","unstructured":"Flak JN, Myers MG Jr (2016) Minireview: CNS Mechanisms of Leptin Action. Mol Endocrinol 30(1):3\u201312. https:\/\/doi.org\/10.1210\/me.2015-1232","journal-title":"Mol Endocrinol"},{"issue":"6","key":"4797_CR186","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.coph.2007.10.010","volume":"7","author":"XY Lu","year":"2007","unstructured":"Lu XY (2007) The leptin hypothesis of depression: a potential link between mood disorders and obesity? Curr Opin Pharmacol 7(6):648\u2013652. https:\/\/doi.org\/10.1016\/j.coph.2007.10.010","journal-title":"Curr Opin Pharmacol"},{"issue":"9","key":"4797_CR187","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.biopsych.2015.10.023","volume":"81","author":"Y Milaneschi","year":"2017","unstructured":"Milaneschi Y, Lamers F, Bot M, Drent ML, Penninx BW (2017) Leptin dysregulation is specifically associated with major depression with atypical features: Evidence for a mechanism connecting obesity and depression. Biol Psychiatry 81(9):807\u2013814. https:\/\/doi.org\/10.1016\/j.biopsych.2015.10.023","journal-title":"Biol Psychiatry"},{"issue":"4","key":"4797_CR188","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1159\/000054641","volume":"73","author":"T Kraus","year":"2001","unstructured":"Kraus T, Haack M, Schuld A, Hinze-Selch D, Pollmacher T (2001) Low leptin levels but normal body mass indices in patients with depression or schizophrenia. Neuroendocrinology 73(4):243\u2013247. https:\/\/doi.org\/10.1159\/000054641","journal-title":"Neuroendocrinology"},{"issue":"1","key":"4797_CR189","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jad.2005.09.015","volume":"90","author":"GM Jow","year":"2006","unstructured":"Jow GM, Yang TT, Chen CL (2006) Leptin and cholesterol levels are low in major depressive disorder, but high in schizophrenia. J Affect Disord 90(1):21\u201327. https:\/\/doi.org\/10.1016\/j.jad.2005.09.015","journal-title":"J Affect Disord"},{"issue":"6","key":"4797_CR190","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.neuron.2006.09.006","volume":"51","author":"S Fulton","year":"2006","unstructured":"Fulton S, Pissios P, Manchon RP, Stiles L, Frank L, Pothos EN, Maratos-Flier E, Flier JS (2006) Leptin regulation of the mesoaccumbens dopamine pathway. Neuron 51(6):811\u2013822. https:\/\/doi.org\/10.1016\/j.neuron.2006.09.006","journal-title":"Neuron"},{"issue":"6","key":"4797_CR191","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.neuron.2006.08.023","volume":"51","author":"JD Hommel","year":"2006","unstructured":"Hommel JD, Trinko R, Sears RM, Georgescu D, Liu ZW, Gao XB, Thurmon JJ, Marinelli M et al (2006) Leptin receptor signaling in midbrain dopamine neurons regulates feeding. Neuron 51(6):801\u2013810. https:\/\/doi.org\/10.1016\/j.neuron.2006.08.023","journal-title":"Neuron"},{"issue":"1","key":"4797_CR192","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1084\/jem.20101940","volume":"208","author":"VK Yadav","year":"2011","unstructured":"Yadav VK, Oury F, Tanaka KF, Thomas T, Wang Y, Cremers S, Hen R, Krust A et al (2011) Leptin-dependent serotonin control of appetite: temporal specificity, transcriptional regulation, and therapeutic implications. J Exp Med 208(1):41\u201352. https:\/\/doi.org\/10.1084\/jem.20101940","journal-title":"J Exp Med"},{"issue":"2","key":"4797_CR193","doi-asserted-by":"publisher","first-page":"R306","DOI":"10.1152\/ajpregu.00350.2005","volume":"290","author":"KA Clark","year":"2006","unstructured":"Clark KA, MohanKumar SM, Kasturi BS, MohanKumar PS (2006) Effects of central and systemic administration of leptin on neurotransmitter concentrations in specific areas of the hypothalamus. Am J Physiol Regul Integr Comp Physiol 290(2):R306-312. https:\/\/doi.org\/10.1152\/ajpregu.00350.2005","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"9","key":"4797_CR194","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1111\/cns.13385","volume":"26","author":"JL Zhao","year":"2020","unstructured":"Zhao JL, Jiang WT, Wang X, Cai ZD, Liu ZH, Liu GR (2020) Exercise, brain plasticity, and depression. CNS Neurosci Ther 26(9):885\u2013895. https:\/\/doi.org\/10.1111\/cns.13385","journal-title":"CNS Neurosci Ther"},{"key":"4797_CR195","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2023.114791","volume":"459","author":"H Alizadeh Pahlavani","year":"2024","unstructured":"Alizadeh Pahlavani H (2024) Possible role of exercise therapy on depression: Effector neurotransmitters as key players. Behav Brain Res 459:114791. https:\/\/doi.org\/10.1016\/j.bbr.2023.114791","journal-title":"Behav Brain Res"},{"key":"4797_CR196","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.jpsychires.2024.04.053","volume":"175","author":"R Fahed","year":"2024","unstructured":"Fahed R, Schulz C, Klaus J, Ellinger S, Walter M, Kroemer NB (2024) Ghrelin is associated with an elevated mood after an overnight fast in depression. J Psychiatr Res 175:271\u2013279. https:\/\/doi.org\/10.1016\/j.jpsychires.2024.04.053","journal-title":"J Psychiatr Res"},{"key":"4797_CR197","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.yhbeh.2015.05.018","volume":"73","author":"MS Antunes","year":"2015","unstructured":"Antunes MS, Ruff JR, de Oliveira ED, Piegas MB, de Brito ML, Rocha KA, de Gomes MG, Goes AT et al (2015) Neuropeptide Y administration reverses tricyclic antidepressant treatment-resistant depression induced by ACTH in mice. Horm Behav 73:56\u201363. https:\/\/doi.org\/10.1016\/j.yhbeh.2015.05.018","journal-title":"Horm Behav"},{"issue":"10277","key":"4797_CR198","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/S0140-6736(21)00359-7","volume":"397","author":"BW Penninx","year":"2021","unstructured":"Penninx BW, Pine DS, Holmes EA, Reif A (2021) Anxiety disorders. Lancet 397(10277):914\u2013927. https:\/\/doi.org\/10.1016\/S0140-6736(21)00359-7","journal-title":"Lancet"},{"issue":"10","key":"4797_CR199","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1080\/14728222.2021.2005027","volume":"25","author":"S Kwon","year":"2021","unstructured":"Kwon S, Cheon SY (2021) Influence of the inflammasome complex on psychiatric disorders: clinical and preclinical studies. Expert Opin Ther Targets 25(10):897\u2013907. https:\/\/doi.org\/10.1080\/14728222.2021.2005027","journal-title":"Expert Opin Ther Targets"},{"issue":"1","key":"4797_CR200","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.neuropharm.2011.08.040","volume":"62","author":"H Mohler","year":"2012","unstructured":"Mohler H (2012) The GABA system in anxiety and depression and its therapeutic potential. Neuropharmacology 62(1):42\u201353. https:\/\/doi.org\/10.1016\/j.neuropharm.2011.08.040","journal-title":"Neuropharmacology"},{"key":"4797_CR201","doi-asserted-by":"publisher","first-page":"102016","DOI":"10.1016\/j.nicl.2019.102016","volume":"24","author":"TA Kolesar","year":"2019","unstructured":"Kolesar TA, Bilevicius E, Wilson AD, Kornelsen J (2019) Systematic review and meta-analyses of neural structural and functional differences in generalized anxiety disorder and healthy controls using magnetic resonance imaging. Neuroimage Clin 24:102016. https:\/\/doi.org\/10.1016\/j.nicl.2019.102016","journal-title":"Neuroimage Clin"},{"issue":"1","key":"4797_CR202","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jad.2012.07.006","volume":"145","author":"JN Pannekoek","year":"2013","unstructured":"Pannekoek JN, Veer IM, van Tol MJ, van der Werff SJ, Demenescu LR, Aleman A, Veltman DJ, Zitman FG et al (2013) Aberrant limbic and salience network resting-state functional connectivity in panic disorder without comorbidity. J Affect Disord 145(1):29\u201335. https:\/\/doi.org\/10.1016\/j.jad.2012.07.006","journal-title":"J Affect Disord"},{"key":"4797_CR203","doi-asserted-by":"publisher","first-page":"247054701770399","DOI":"10.1177\/2470547017703993","volume":"1","author":"MA Patriquin","year":"2017","unstructured":"Patriquin MA, Mathew SJ (2017) The neurobiological mechanisms of generalized anxiety disorder and chronic stress. Chronic Stress (Thousand Oaks) 1:2470547017703993. https:\/\/doi.org\/10.1177\/2470547017703993","journal-title":"Chronic Stress (Thousand Oaks)"},{"issue":"1","key":"4797_CR204","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1038\/s41386-021-01109-z","volume":"47","author":"MM Kenwood","year":"2022","unstructured":"Kenwood MM, Kalin NH, Barbas H (2022) The prefrontal cortex, pathological anxiety, and anxiety disorders. Neuropsychopharmacology 47(1):260\u2013275. https:\/\/doi.org\/10.1038\/s41386-021-01109-z","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"4797_CR205","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/j.cll.2010.07.006","volume":"30","author":"EI Martin","year":"2010","unstructured":"Martin EI, Ressler KJ, Binder E, Nemeroff CB (2010) The neurobiology of anxiety disorders: brain imaging, genetics, and psychoneuroendocrinology. Clin Lab Med 30(4):865\u2013891. https:\/\/doi.org\/10.1016\/j.cll.2010.07.006","journal-title":"Clin Lab Med"},{"issue":"4","key":"4797_CR206","first-page":"133","volume":"37","author":"CB Nemeroff","year":"2003","unstructured":"Nemeroff CB (2003) The role of GABA in the pathophysiology and treatment of anxiety disorders. Psychopharmacol Bull 37(4):133\u2013146","journal-title":"Psychopharmacol Bull"},{"issue":"10","key":"4797_CR207","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1017\/s1092852900010427","volume":"10","author":"BM Cortese","year":"2005","unstructured":"Cortese BM, Phan KL (2005) The role of glutamate in anxiety and related disorders. CNS Spectr 10(10):820\u2013830. https:\/\/doi.org\/10.1017\/s1092852900010427","journal-title":"CNS Spectr"},{"issue":"Suppl 11","key":"4797_CR208","first-page":"22","volume":"62","author":"DJ Nutt","year":"2001","unstructured":"Nutt DJ (2001) Neurobiological mechanisms in generalized anxiety disorder. J Clin Psychiatry 62(Suppl 11):22\u201327 (discussion 28)","journal-title":"J Clin Psychiatry"},{"issue":"3","key":"4797_CR209","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1523\/JNEUROSCI.4921-03.2004","volume":"24","author":"A Neumeister","year":"2004","unstructured":"Neumeister A, Bain E, Nugent AC, Carson RE, Bonne O, Luckenbaugh DA, Eckelman W, Herscovitch P et al (2004) Reduced serotonin type 1A receptor binding in panic disorder. J Neurosci 24(3):589\u2013591. https:\/\/doi.org\/10.1523\/JNEUROSCI.4921-03.2004","journal-title":"J Neurosci"},{"key":"4797_CR210","doi-asserted-by":"publisher","first-page":"1173326","DOI":"10.3389\/fnsys.2023.1173326","volume":"17","author":"NN Bouras","year":"2023","unstructured":"Bouras NN, Mack NR, Gao WJ (2023) Prefrontal modulation of anxiety through a lens of noradrenergic signaling. Front Syst Neurosci 17:1173326. https:\/\/doi.org\/10.3389\/fnsys.2023.1173326","journal-title":"Front Syst Neurosci"},{"key":"4797_CR211","doi-asserted-by":"publisher","first-page":"1118836","DOI":"10.3389\/fpsyt.2023.1118836","volume":"14","author":"S Ji","year":"2023","unstructured":"Ji S, Chen Y, Zhou Y, Cao Y, Li X, Ding G, Tang F (2023) Association between anxiety and metabolic syndrome: An updated systematic review and meta-analysis. Front Psychiatry 14:1118836. https:\/\/doi.org\/10.3389\/fpsyt.2023.1118836","journal-title":"Front Psychiatry"},{"issue":"9","key":"4797_CR212","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/j.metabol.2014.06.002","volume":"63","author":"ML Moon","year":"2014","unstructured":"Moon ML, Joesting JJ, Lawson MA, Chiu GS, Blevins NA, Kwakwa KA, Freund GG (2014) The saturated fatty acid, palmitic acid, induces anxiety-like behavior in mice. Metabolism 63(9):1131\u20131140. https:\/\/doi.org\/10.1016\/j.metabol.2014.06.002","journal-title":"Metabolism"},{"issue":"3","key":"4797_CR213","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1176\/ajp.149.3.376","volume":"149","author":"WK Bajwa","year":"1992","unstructured":"Bajwa WK, Asnis GM, Sanderson WC, Irfan A, van Praag HM (1992) High cholesterol levels in patients with panic disorder. Am J Psychiatry 149(3):376\u2013378. https:\/\/doi.org\/10.1176\/ajp.149.3.376","journal-title":"Am J Psychiatry"},{"key":"4797_CR214","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1744-9081-10-30","volume":"10","author":"X Hu","year":"2014","unstructured":"Hu X, Wang T, Luo J, Liang S, Li W, Wu X, Jin F, Wang L (2014) Age-dependent effect of high cholesterol diets on anxiety-like behavior in elevated plus maze test in rats. Behav Brain Funct 10:30. https:\/\/doi.org\/10.1186\/1744-9081-10-30","journal-title":"Behav Brain Funct"},{"issue":"2","key":"4797_CR215","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.psyneuen.2012.05.017","volume":"38","author":"AK van Reedt Dortland","year":"2013","unstructured":"van Reedt Dortland AK, Vreeburg SA, Giltay EJ, Licht CM, Vogelzangs N, van Veen T, de Geus EJ, Penninx BW et al (2013) The impact of stress systems and lifestyle on dyslipidemia and obesity in anxiety and depression. Psychoneuroendocrinology 38(2):209\u2013218. https:\/\/doi.org\/10.1016\/j.psyneuen.2012.05.017","journal-title":"Psychoneuroendocrinology"},{"issue":"10","key":"4797_CR216","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.2337\/diacare.27.10.2335","volume":"27","author":"AJ Sommerfield","year":"2004","unstructured":"Sommerfield AJ, Deary IJ, Frier BM (2004) Acute hyperglycemia alters mood state and impairs cognitive performance in people with type 2 diabetes. Diabetes Care 27(10):2335\u20132340. https:\/\/doi.org\/10.2337\/diacare.27.10.2335","journal-title":"Diabetes Care"},{"issue":"1","key":"4797_CR217","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/s41380-018-0102-9","volume":"24","author":"F Sun","year":"2019","unstructured":"Sun F, Lei Y, You J, Li C, Sun L, Garza J, Zhang D, Guo M et al (2019) Adiponectin modulates ventral tegmental area dopamine neuron activity and anxiety-related behavior through AdipoR1. Mol Psychiatry 24(1):126\u2013144. https:\/\/doi.org\/10.1038\/s41380-018-0102-9","journal-title":"Mol Psychiatry"},{"issue":"1","key":"4797_CR218","first-page":"9","volume":"55","author":"T Yamauchi","year":"2009","unstructured":"Yamauchi T, Inoue K, Iwasaki S, Muramatsu T, Hayashi T, Kiriike N (2009) Intracerebroventricular administration of leptin increases anxiety-like behavior in female rats after semi-starvation\u2013implications for anxiety in eating disorders. Osaka City Med J 55(1):9\u201318","journal-title":"Osaka City Med J"},{"key":"4797_CR219","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.cca.2012.12.007","volume":"417","author":"A Yadav","year":"2013","unstructured":"Yadav A, Kataria MA, Saini V, Yadav A (2013) Role of leptin and adiponectin in insulin resistance. Clin Chim Acta 417:80\u201384. https:\/\/doi.org\/10.1016\/j.cca.2012.12.007","journal-title":"Clin Chim Acta"},{"key":"4797_CR220","doi-asserted-by":"publisher","first-page":"658913","DOI":"10.1155\/2014\/658913","volume":"2014","author":"E Nigro","year":"2014","unstructured":"Nigro E, Scudiero O, Monaco ML, Palmieri A, Mazzarella G, Costagliola C, Bianco A, Daniele A (2014) New insight into adiponectin role in obesity and obesity-related diseases. Biomed Res Int 2014:658913. https:\/\/doi.org\/10.1155\/2014\/658913","journal-title":"Biomed Res Int"},{"issue":"8","key":"4797_CR221","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1038\/90984","volume":"7","author":"T Yamauchi","year":"2001","unstructured":"Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, Mori Y, Ide T et al (2001) The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 7(8):941\u2013946. https:\/\/doi.org\/10.1038\/90984","journal-title":"Nat Med"},{"key":"4797_CR222","doi-asserted-by":"publisher","first-page":"819","DOI":"10.3389\/fendo.2019.00819","volume":"10","author":"J Bloemer","year":"2019","unstructured":"Bloemer J, Pinky PD, Smith WD, Bhattacharya D, Chauhan A, Govindarajulu M, Hong H, Dhanasekaran M et al (2019) Adiponectin Knockout Mice Display Cognitive and Synaptic Deficits. Front Endocrinol (Lausanne) 10:819. https:\/\/doi.org\/10.3389\/fendo.2019.00819","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"4797_CR223","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.jad.2012.03.022","volume":"139","author":"C Unsal","year":"2012","unstructured":"Unsal C, Hariri AG, Yanartas O, Sevinc E, Atmaca M, Bilici M (2012) Low plasma adiponectin levels in panic disorder. J Affect Disord 139(3):302\u2013305. https:\/\/doi.org\/10.1016\/j.jad.2012.03.022","journal-title":"J Affect Disord"},{"issue":"6","key":"4797_CR224","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1007\/s00406-019-01051-8","volume":"271","author":"PSV Salerno","year":"2021","unstructured":"Salerno PSV, Bastos CR, Peres A, Ardais AP, Gazal M, Jansen K, Souza LDM, da Silva RA et al (2021) Leptin polymorphism rs3828942: risk for anxiety disorders? Eur Arch Psychiatry Clin Neurosci 271(6):1141\u20131148. https:\/\/doi.org\/10.1007\/s00406-019-01051-8","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"10","key":"4797_CR225","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1038\/mp.2011.36","volume":"16","author":"J Liu","year":"2011","unstructured":"Liu J, Perez SM, Zhang W, Lodge DJ, Lu XY (2011) Selective deletion of the leptin receptor in dopamine neurons produces anxiogenic-like behavior and increases dopaminergic activity in amygdala. Mol Psychiatry 16(10):1024\u20131038. https:\/\/doi.org\/10.1038\/mp.2011.36","journal-title":"Mol Psychiatry"},{"issue":"12","key":"4797_CR226","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1111\/pcn.12922","volume":"73","author":"S Cernea","year":"2019","unstructured":"Cernea S, Both E, Hutanu A, Sular FL, Roiban AL (2019) Correlations of serum leptin and leptin resistance with depression and anxiety in patients with type 2 diabetes. Psychiatry Clin Neurosci 73(12):745\u2013753. https:\/\/doi.org\/10.1111\/pcn.12922","journal-title":"Psychiatry Clin Neurosci"},{"issue":"3","key":"4797_CR227","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3109\/10520295.2013.825319","volume":"89","author":"M Ates","year":"2014","unstructured":"Ates M, Dayi A, Kiray M, Sisman AR, Agilkaya S, Aksu I, Baykara B, Buyuk E et al (2014) Anxiety- and depression-like behavior are correlated with leptin and leptin receptor expression in prefrontal cortex of streptozotocin-induced diabetic rats. Biotech Histochem 89(3):161\u2013171. https:\/\/doi.org\/10.3109\/10520295.2013.825319","journal-title":"Biotech Histochem"},{"issue":"4","key":"4797_CR228","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s00213-009-1684-3","volume":"207","author":"J Liu","year":"2010","unstructured":"Liu J, Garza JC, Bronner J, Kim CS, Zhang W, Lu XY (2010) Acute administration of leptin produces anxiolytic-like effects: a comparison with fluoxetine. Psychopharmacology 207(4):535\u2013545. https:\/\/doi.org\/10.1007\/s00213-009-1684-3","journal-title":"Psychopharmacology"},{"issue":"2","key":"4797_CR229","doi-asserted-by":"publisher","first-page":"pyv115","DOI":"10.1093\/ijnp\/pyv115","volume":"19","author":"J Liu","year":"2015","unstructured":"Liu J, Guo M, Lu XY (2015) Leptin\/LepRb in the Ventral Tegmental Area Mediates Anxiety-Related Behaviors. Int J Neuropsychopharmacol 19(2):pyv115. https:\/\/doi.org\/10.1093\/ijnp\/pyv115","journal-title":"Int J Neuropsychopharmacol"},{"issue":"2","key":"4797_CR230","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/s1056-8727(02)00185-x","volume":"17","author":"A Asakawa","year":"2003","unstructured":"Asakawa A, Inui A, Inui T, Katsuura G, Fujino MA, Kasuga M (2003) Leptin treatment ameliorates anxiety in ob\/ob obese mice. J Diabetes Complications 17(2):105\u2013107. https:\/\/doi.org\/10.1016\/s1056-8727(02)00185-x","journal-title":"J Diabetes Complications"},{"key":"4797_CR231","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3389\/fpsyt.2013.00027","volume":"4","author":"E Anderson","year":"2013","unstructured":"Anderson E, Shivakumar G (2013) Effects of exercise and physical activity on anxiety. Front Psychiatry 4:27. https:\/\/doi.org\/10.3389\/fpsyt.2013.00027","journal-title":"Front Psychiatry"},{"key":"4797_CR232","doi-asserted-by":"publisher","first-page":"1362731","DOI":"10.3389\/fnut.2024.1362731","volume":"11","author":"F Kazeminasab","year":"2024","unstructured":"Kazeminasab F, Behzadnejad N, Cerqueira HS, Santos HO, Rosenkranz SK (2024) Effects of intermittent fasting combined with exercise on serum leptin and adiponectin in adults with or without obesity: a systematic review and meta-analysis of randomized clinical trials. Front Nutr 11:1362731. https:\/\/doi.org\/10.3389\/fnut.2024.1362731","journal-title":"Front Nutr"},{"issue":"1","key":"4797_CR233","doi-asserted-by":"publisher","first-page":"e33475","DOI":"10.7759\/cureus.33475","volume":"15","author":"A Mahindru","year":"2023","unstructured":"Mahindru A, Patil P, Agrawal V (2023) Role of physical activity on mental health and well-being: A review. Cureus 15(1):e33475. https:\/\/doi.org\/10.7759\/cureus.33475","journal-title":"Cureus"},{"issue":"4","key":"4797_CR234","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1097\/MOL.0000000000000689","volume":"31","author":"FK Welty","year":"2020","unstructured":"Welty FK (2020) Dietary treatment to lower cholesterol and triglyceride and reduce cardiovascular risk. Curr Opin Lipidol 31(4):206\u2013231. https:\/\/doi.org\/10.1097\/MOL.0000000000000689","journal-title":"Curr Opin Lipidol"},{"key":"4797_CR235","doi-asserted-by":"publisher","first-page":"726861","DOI":"10.1155\/2014\/726861","volume":"2014","author":"S Golbidi","year":"2014","unstructured":"Golbidi S, Laher I (2014) Exercise induced adipokine changes and the metabolic syndrome. J Diabetes Res 2014:726861. https:\/\/doi.org\/10.1155\/2014\/726861","journal-title":"J Diabetes Res"},{"key":"4797_CR236","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jnutbio.2018.02.012","volume":"58","author":"K Albracht-Schulte","year":"2018","unstructured":"Albracht-Schulte K, Kalupahana NS, Ramalingam L, Wang S, Rahman SM, Robert-McComb J, Moustaid-Moussa N (2018) Omega-3 fatty acids in obesity and metabolic syndrome: a mechanistic update. J Nutr Biochem 58:1\u201316. https:\/\/doi.org\/10.1016\/j.jnutbio.2018.02.012","journal-title":"J Nutr Biochem"},{"issue":"1","key":"4797_CR237","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/s41398-019-0515-5","volume":"9","author":"Y Liao","year":"2019","unstructured":"Liao Y, Xie B, Zhang H, He Q, Guo L, Subramanieapillai M, Fan B, Lu C et al (2019) Efficacy of omega-3 PUFAs in depression: A meta-analysis. Transl Psychiatry 9(1):190. https:\/\/doi.org\/10.1038\/s41398-019-0515-5","journal-title":"Transl Psychiatry"},{"issue":"5","key":"4797_CR238","doi-asserted-by":"publisher","first-page":"e182327","DOI":"10.1001\/jamanetworkopen.2018.2327","volume":"1","author":"KP Su","year":"2018","unstructured":"Su KP, Tseng PT, Lin PY, Okubo R, Chen TY, Chen YW, Matsuoka YJ (2018) Association of use of omega-3 polyunsaturated fatty acids with changes in severity of anxiety symptoms: A systematic review and meta-analysis. JAMA Netw Open 1(5):e182327. https:\/\/doi.org\/10.1001\/jamanetworkopen.2018.2327","journal-title":"JAMA Netw Open"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-04797-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-025-04797-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-04797-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T15:29:29Z","timestamp":1751383769000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-025-04797-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,5]]},"references-count":238,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["4797"],"URL":"https:\/\/doi.org\/10.1007\/s12035-025-04797-6","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,5]]},"assertion":[{"value":"19 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}}]}}